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Abstract
Single-cell sequencing is rapidly transforming biomedical research. With the ability
to measure omics information in individual cells, it provides unprecedented resolu-
tion to study heterogeneous biological and clinical samples, enabling scientists to
discover and characterize previously unknown biological signals and processes carried
by novel or rare cell subpopulations. The new data structure and high level of noise
in the single-cell genomic data pose significant analytical challenges. To address these
challenges, we developed new statistical and computational methods for analyzing
single-cell transcriptome and regulome data. First, to infer cells’ underlying devel-
opmental trajectories, we developed TSCAN that performs “pseudotime” analysis
with a cluster-based minimum spanning tree approach. TSCAN facilitates accurate
construction of pseudotemporal trajectories by regularizing the complexity of span-
ning trees. By improving the bias-variance tradeoff of the spanning tree estimation,
TSCAN substantially improved the accuracy and robustness of the pseudotime anal-
ysis. Second, we developed RAISIN to support regression and differential analysis
in single-cell RNA-seq datasets with multiple samples. Compared to classical linear
mixed effects model, RAISIN improves variance estimate and statistical power for
datasets with small sample size or cell number, and improves scalability for datasets
with large sample size and millions of cells. Third, we developed SCATE to extract and
enhance signals from the highly noisy and sparse single-cell ATAC-seq data. SCATE
accurately infers genome-wide activities of each individual cis-regulatory element by
adaptively integrating information from co-activated cis-regulatory elements, similar
ii
cells, and massive amounts of publicly available regulome data. The enhanced signal
improves the performance of downstream analyses such as peak calling and prediction
of transcription factor binding sites. These methods have been applied in numer-
ous collaborative projects and helped decipher gene regulatory programs in T cell
exhaustion process and identify molecular signatures in neoadjuvant immunotherapy.
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Gene expression is an essential process in all known life forms. Gene expression is
the process where the information of a gene is used to synthesize functional gene
products such as ribonucleic acid (RNA) and proteins. Gene expression can be
regulated by a wide range of sophisticated mechanisms in almost all steps of the gene
expression process including transcription [1], RNA splicing [2], and translation and
post-translational modification of a protein [3]. Gene regulation controls the timing,
location, and amount of gene products present in a cell, and it has a profound impact on
the functions of cells. The regulation of gene expression is the basis of many biological
processes such as cell differentiation and development. Misregulation of gene expression
can cause many diseases including cancer, autoimmune disease, developmental disorder,
diabetes, cardiovascular disease and others [4]. Thus, decoding the dynamic gene
expression process and elucidating how gene expression is regulated are essential
for understanding the mechanisms of these complex diseases and developing better
intervention and treatment strategies.
Next-generation sequencing (NGS) [5] is a powerful tool to study and under-
stand the gene expression process and how genes are regulated. The classical NGS
technologies measure different perspectives of the gene expression process for a cell
population at a given time point. For example, RNA sequencing (RNA-seq) [6] mea-
sures the transcriptome, which is the complete set of transcripts and their quantity in a
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sample. DNase I hypersensitive sites sequencing (DNase-seq) [7], assay for transposase-
accessible chromatin sequencing (ATAC-seq) [8], and formaldehyde-assisted isolation
of regulatory elements sequencing (FAIRE-seq) [9] measure genome-wide chromatin
accessibility, which correlates with the degree to which nuclear macromolecules are
able to physically contact chromatinized DNA [10]. Chromatin immunoprecipitation
sequencing (ChIP-seq) [11] identifies the binding sites of DNA-associated proteins.
Whole genome bisulfite sequencing (WGBS) [12] determines the DNA methylation
status of single cytosines. NGS technologies have been widely applied in biomedical
research. For example, the ENCODE project [13] has generated data using different
types of NGS technologies for more than 16,000 samples by far, covering different
species, cell types, tissues, developmental stage, and chemical treatments. This pro-
vides a rich resource for studying gene expression and gene regulation in a wide variety
of biological contexts.
One limitation of the conventional NGS technology, or bulk sequencing technology,
is that it only measures the averaged genomic information of a cell population. For
example, DNase-seq usually requires one million cells [14] and ATAC-seq requires
hundreds to thousands of cells [15]. They measure these cells’ average behavior.
However, in many situations, the genomic information for each cell is desired. For
a heterogeneous cell population such as cancer, measuring the genomic information
for each cell may reveal a clue for rare but critical cell subpopulation such as cancer
stem cell [16]. This information is masked by bulk sequencing. Identifying such cell
subpopulation may provide key insights into the failure of anticancer therapies [16].
Even for a homogeneous cell population, gene expression can also be heterogeneous
due to stochastic variations [17]. The genomic information for each cell may help
reveal how the stochastic events link to cell fate decisions [18]. Finally, it is very
difficult, if not impossible, for bulk sequencing to study a cell population with a very
small number of cells. For example, there are only a few precursor cells available of
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specific lineages from very early embryos [19]. Thus, it becomes crucial to develop
new sequencing technologies that can measure the genomic information in a single cell.
Such single-cell technology can help researchers to gain deeper understandings of basic
biology and clinical practice which cannot be learned using bulk sequencing alone.
Thanks to the rapid development of the technology and experimental protocol,
different types of single-cell sequencing technology have been developed in the past
decade. The first generation of single-cell RNA-seq technologies was developed around
ten years ago [20–22]. These technologies were able to measure the transcriptome in
one or a few cells. After that, the number of single cells measured in a study increases
exponentially [23]. Single-cell RNA-seq has now become a widely accessible tool to
measure the transcriptome of hundreds of thousands of cells [24–26]. Single-cell RNA-
seq has been widely applied in numerous fields of biomedical research, such as studying
the dynamic changes of transcriptome in a developmental process [27], the immune
cells in breast cancer tumor microenvironment [28], the developmental lineage of a
whole animal [29], the spatial transcriptome of the mouse brain [30], and identifying
new cell types in mouse kidney [31]. Meanwhile, single-cell sequencing technology
to characterize the activities of all genomic regulatory elements, or regulome, starts
to emerge around five years ago. Single-cell ATAC-seq (scATAC-seq [32, 33]) and
single-cell DNase-seq (scDNase-seq [14]) are two technologies for measuring chromatin
accessibility in single cells. Single-cell ChIP-seq (scChIP-seq [34]) measures histone
modifications in single cells. These technologies have been used to uncover the
composition of different cell types in a cell population, as well as to find a link between
chromatin organization and cell-to-cell variation [32]. There are also technologies
developed for mapping different -omics modalities simultaneously in single cells. For
example, sci-CAR can jointly profile chromatin accessibility and mRNA in thousands
of single cells [35]. Other types of single-cell sequencing technologies include single-cell
genome sequencing [36], single-cell DNA methylation sequencing [37], and paired
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single-cell T cell receptor sequencing (TCR-seq) and RNA-seq [38].
However, analyzing data generated from single-cell sequencing technologies is an
enormous challenge. Analytical methods developed for conventional bulk sequencing
data usually are incapable of dealing with the unique challenges in analyzing single-
cell data. First, new types of analytical tasks may emerge when analyzing data
from single-cell sequencing. For example, to study a continuous biological process
such as cell differentiation, one can collect time-course single-cell RNA-seq datasets
from different experimental time points. However, cells may differentiate at different
speeds, and the experimental time points may not represent the cells’ true states
in the differentiation trajectory. How to computationally order the cells to reflect
the underlying biological process is a new challenge that is not seen in analyzing
bulk sequencing data. Second, data from single-cell technology can be highly sparse
and noisy. For example, data from 10x single-cell RNA-seq [24] can have as high as
90-95% of all gene expression measurements to be zero. Many of these zeroes are
the so-called dropout events, where the observed zero read count does not represent
the actual medium or high expression of the gene due to some technical bias. Data
from single-cell ATAC-seq are even more sparse and are nearly binary. This happens
because the diploid genome only has two copies of DNA and single-cell ATAC-seq
only has a chance of one or two to capture the open chromatin regions. However,
molecular events such as transcription factor binding to DNA is a temporal stochastic
event. Thus, the highly sparse single-cell ATAC-seq signal cannot accurately describe
the probability of the occurrence of molecular events, which is a continuous measure.
Thus, it is essential to develop analytical methods to recover the true signal from
the highly sparse and noisy single-cell sequencing data. Third, data from single-cell
technology can be highly complex. Consider a gene expression dataset with multiple
samples. For each sample, traditional bulk technology will generate a vector of gene
expression values across all genes, while single-cell technology will generate a matrix
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of gene expression values across all genes and cells. Thus, while bulk data contains the
variability across samples, single-cell data add an extra layer of variability across cells.
More sophisticated analytical methods are needed to account for the extra complexity
of the data. There are many other challenges as well, including how to develop scalable
methods to analyze big single-cell datasets and how to integrate information from
different single-cell data modalities.
To tackle these challenges, many novel statistical and computational methods have
been developed. For example, pseudotime or trajectory analysis methods [39] have
been proposed to tackle the new challenge of ordering cells computationally to infer
their underlying biology. Imputation methods have been developed to tackle the high
sparsity issue of the single-cell RNA-seq data [40]. New methods [41, 42] have also
been created to handle the complex structure of the single-cell datasets. However,
there are still many unsolved challenges. For example, although there are methods to
impute single-cell RNA-seq data, there is no existing method to accurately recover
the activities of genome-wide cis-regulatory elements (CREs).
This thesis introduces three methods we developed to tackle several open challenges
in single-cell data analyses. TSCAN [43] is a pseudotime analysis method that
computationally orders the cells and infers the underlying biological process. TSCAN
reaches a better performance of pseudotime analysis by improving the bias-variance
tradeoff in spanning tree inference. SCATE enhances highly sparse single-cell ATAC-
seq signal and recovers activities of genome-wide CREs by adaptively integrating
information from co-activated CREs, similar cells, and massive amounts of publicly
available regulome data. RAISIN is a regression and differential analysis method that
adequately accounts for the multi-level variance structure in single-cell RNA-seq data
with multiple samples. We demonstrate that these methods can tackle the unique
challenges in analyzing single-cell sequencing data with systematic benchmarking
studies. We are applying these methods in several collaborative projects. Examples
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include studying the mechanisms of the T cell exhaustion process [44] and deciphering




Reconstruction and Evaluation in
Single-cell RNA-seq Analysis
2.1 Introduction
Single-cell RNA-seq is a transformative technology that allows researchers to measure
transcriptomes of individual cells [20, 45]. Unlike single-cell RNA-seq, conventional
RNA-seq (also referred to as “bulk RNA-seq”) [6, 46] or microarray [47, 48] experiments
are used to measure average gene expression of a cell population. In many applications,
the cell population is heterogeneous and contains multiple cell types. As a result, the
average transcriptome of the population may fail to capture important transcriptional
signals in individual cells. Sometimes, using the population average to study cell type
specific behavior can also be misleading due to Simpson’s paradox [27, 49]. With the
ability to measure the transcriptome of each individual cell, single-cell RNA-seq is
capable of generating a higher resolution view of the gene expression landscape in a
heterogeneous cell population [21, 22, 50]. This can lead to a more accurate molecular
characterization of a complex biological phenomenon [51].
As demonstrated by [27], one useful way to gain biological insights from single-cell
RNA-seq data is to computationally order cells according to the gradual transition of
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their transcriptomes. For example, in a cell differentiation process, cells can evolve
at different speeds. A sample of cells collected at a particular time point during
differentiation can actually contain cells representing different differentiation stages.
Using single-cell RNA-seq data, one may construct an ordered sequence of cells to
describe the gradual transition of the single-cell transcriptome. If this in silico order is
consistent with cells’ true differentiation stages, then by analyzing how gene expression
changes along this ordered sequence of cells, one will be able to obtain insights on the
transcriptome dynamics during the differentiation process. The process of ordering
cells in silico is called pseudo-time reconstruction because it mimics a procedure
that places cells on a time axis. Despite the use of the term “time”, “pseudo-time
reconstruction” can more generally refer to any cell ordering procedure regardless of
whether the ordering has a time interpretation (e.g., the ordering of cells may reflect
cells’ spatial order rather than their temporal order).
Several computational methods have been proposed to analyze single-cell genomic
data such as single-cell mass cytometry data [52–54] and single-cell gene expression
data [27, 55–58]. However, for pseudo-time reconstruction in single-cell RNA-seq data,
there are only a limited number of methods that have been systematically tested and
have easily accessible software tools. In [27], an unsupervised approach Monocle was
proposed to solve this problem. Monocle uses a minimum spanning tree (MST) to
describe the transition structure among cells. The backbone of the tree is extracted to
serve as the pseudo-time axis to place cells in order. A similar unsupervised spanning-
tree approach has also been used previously for analyzing flow cytometry data [54]. As
an unsupervised approach, pseudo-time reconstruction based on spanning trees does
not require any prior information on cell ordering. When temporal order information
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is available, an alternative approach to analyzing single-cell gene expression dynamics
is to use such information to supervise the analysis. An example of this supervised
approach is SCUBA [55]. SCUBA uses bifurcation analysis to recover biological
lineages from single-cell gene expression data collected from multiple time points. Here
the multiple time points in a time course experiment are used to supervise the cell
ordering and analyses of gene expression dynamics in cell differentiation processes.
By using the available time information, supervised methods can be more accurate
than unsupervised methods. However, in applications where time information is not
available (e.g., if one needs to analyze a heterogeneous cell population from a single
disease sample rather than from a time course experiment), the supervised approach is
not applicable and one has to rely on unsupervised methods. For these reasons, both
supervised and unsupervised methods are useful. The primary focus of this article is
the unsupervised approach.
One potential limitation of Monocle is that its tree is constructed to connect
individual cells. Since the cell number is large, the tree space is highly complex.
Tree inference in such a complex space is associated with high variability and can
be highly unstable. As a result, the optimal tree found by the algorithm may not
represent cells’ true biological order. This can be illustrated using a toy example
in Figure 2-1A-C. Here dots represent cells placed in a two dimensional space (e.g.,
the space corresponding to the top two principal components of the gene expression
profiles), and the true biological time runs top-down vertically. The MST solution
is not unique. Figure 2-1A and Figure 2-1B show two possible solutions. When a
slight measurement noise pushes the cell labeled by ‘*’ away from other cells, the
tree in Figure 2-1A can easily become a better solution based on the MST algorithm.
However, this solution places cells in an order different from their true biological order.
One approach that may alleviate this problem is to reduce the complexity of the tree
space. This is analogous to the bias-variance tradeoff in the statistics and machine
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learning literature. For instance, if one clusters similar cells together as in Figure 2-1C
and then constructs a tree to connect the cluster centers, recovering the true time-axis
becomes easier. In this article, we exploit this idea to develop TSCAN, a new tool for
pseudo-time reconstruction. One additional advantage offered by clustering cells is
that users can more easily adjust the order of tree nodes (i.e., cell clusters) manually
if they want to do so, since the number of clusters usually is not big. By contrast,
manually specifying the order of hundreds of cells is much more difficult.
Another limitation of existing tools is that they are mostly command-line driven
and do not allow users to interactively adjust or fine-tune the analysis. For example,
users often want to use their existing knowledge such as marker genes to filter out
contamination cells, determine the time origin, or manually change the order of
certain tree nodes. However, these operations are not convenient for a command-
line driven software tool such as Monocle. TSCAN addresses this limitation by
providing a graphical user interface (GUI) (Figure 2-2). Using the GUI, users can
interactively and conveniently incorporate prior biological information into the pseudo-
time reconstruction analysis.
Last but not least, when several different pseudo-time reconstruction methods are
available, being able to evaluate and compare them to identify the best solution is
important. However, how to evaluate different pseudo-time reconstruction methods is
also an open problem. Objective measures for comparing different methods are still
lacking. This article introduces several quantitative measures for evaluating different
cell ordering methods. Using these objective measures, we show that TSCAN is
capable of providing more reliable unsupervised pseudo-time reconstruction results
compared to alternative methods.
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Figure 2-1. TSCAN Overview. (A-B) A toy example illustrating a limitation of cell-based
MST. Here cells (blue circles) are placed in a two dimensional space, and the true biological
time runs top-down. An MST that connects cells is not unique. Both (A) and (B) are
possible solutions. (B) is more consistent with the truth. However, in reality, random
measurement noise may shift the cell labeled by ’*’ away from other cells as indicated by
the arrow and dashed lines. As a result, (B) is no longer an MST. The MST in (A) on the
other hand does not reflect the true order of cells. (C) The true time-axis can be found if
one first groups similar cells into clusters and then constructs an MST to connect cluster
centers. (D) TSCAN first constructs cluster-based MST (five clusters of cells encoded by
different colors are shown as an example; numbers indicate cluster centers). The tree can
have multiple paths (e.g., 1-2-3-4 or 1-2-3-5). TSCAN orders cells along each path by
projecting each cell onto the tree edge. (E) The number of principal components to retain
is determined by finding the best piecewise linear fit consisting of two lines (dashed).
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Figure 2-2. TSCAN graphical user interface. Left panel contains function menus and
tools for setting parameters. Right panel displays data and results. The top scatter plot
shows the MST constructed for the LPS data (see Results). Cells (dots) are displayed
based on their first two principal components. Clusters of cells are indicated by different
colors. Numbers are cluster centers. Expression level of a marker gene BCL3 is shown for
each cell. Larger marker size means higher expression. The bottom plot shows the average




Consider a representative sample of N cells drawn from a heterogeneous cell population.
Suppose the transcriptome Yi of each cell i ∈ {1, 2, . . . , N} has been profiled using
single-cell RNA-seq. Here Yi is a G dimensional vector consisting of gene expression
measurements for G genes. Assume that Yi is appropriately transformed (e.g., by
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taking logarithm) and normalized across cells. The single cell ordering problem, also
called pseudo-time reconstruction, is to place cells in an order based on the gradual
transition of Yi.
TSCAN orders cells in three steps. First, cells with similar gene expression profiles
are grouped into clusters. Second, a minimum spanning tree (MST) is constructed
to connect all cluster centers. Finally, cells are projected to the tree backbone to
determine their pseudo-time and order (Figure 2-1D). Once cells are ordered, users may
use the ordered sequence to study cell state transition and gene expression dynamics
in the underlying biological process from which the cells are sampled.
2.2.2 Preprocessing
Before pseudo-time reconstruction, the raw gene expression data are processed as
follows. First, genes with zero read count in all samples are excluded. Second, in
order to alleviate the effect of drop-out events [59] on the subsequent analyses, genes
with similar expression patterns are grouped into clusters by hierarchical clustering
(using Euclidean distance and complete linkage). The number of clusters is set to be
5% of the total number of genes with non-zero expression. For each cluster and each
cell, the expression measurements of all genes in the cluster are averaged to produce
a cluster-level expression which will be used for subsequent MST construction. The
drop-out event refers to the phenomenon that expressed genes, some of which are
highly expressed, may have zero read count in some cells as their molecules may not
be captured and amplified by chance. This is a common phenomenon in single-cell
RNA-seq data. By averaging across many genes, the cluster-level expression is more
stable and has smaller estimation variance compared to the measurements of individual
genes. This can help to dilute the impact of drop-out events.
After gene clustering, single-cell transcriptome for cell i becomes a H dimensional
vector Ei. Here H is the number of gene clusters. Ei still has high dimension,
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and many components in this vector are still correlated. The dimensionality makes
visualization and statistical modeling difficult. For this reason, TSCAN further reduces
the dimension of Ei using principal component analysis (PCA). Briefly, Ei from all
cells are organized into a H ×N matrix E. Each row corresponds to a gene cluster.
The matrix is standardized such that expression values within each row have zero
mean and unit standard deviation. Then PCA is run on the standardized matrix, and
the top K principal components (PCs) are retained. After PCA, the H dimensional
vector Ei is mapped to a lower dimensional space and becomes a K dimensional vector
Ẽi. Here K is much smaller than H.
In order to determine K (i.e., how many PCs to retain), TSCAN uses the following
criterion. First, let λi be the data variance explained by the ith PC. Define vi ≡
√
λi.
vi is a non-increasing function of i. This function can be approximated using a
continuous piecewise linear model vi = f(i) + ϵ where ϵ represents noise and f(i)
consists of two regression lines (Figure 2-1E):
f(i) =
⎧⎨⎩α0 + α1 ∗ i if i ≤ kβ0 + β1 ∗ i if i > k
s.t. α0 + α1 ∗ k = β0 + β1 ∗ k (2.1)
TSCAN computes the least squares fit of this model using the first 20 PCs. The fitted
model varies when one changes k. TSCAN tries different k ∈ [2, 19] and finds the k
that produces the smallest squared error, ∑︁20i=1[vi − f(i)]2. This k will be used as the
number of PCs to retain.
2.2.3 Cell clustering
After dimension reduction, cells with similar expression profiles are grouped into
clusters using the model-based clustering approach described in [60]. The clustering
is performed using the mclust [61] package in R which fits a mixture of multivariate
normal distributions to the data Ẽi. The variance-covariance matrix for each normal
14
component in this mixture is designated as “ellipsoidal, varying volume, shape, and
orientation”. The number of clusters is chosen by mclust using the Bayesian Information
Criterion (BIC). After model fitting, the posterior probability that each cell belongs
to each cluster can be computed. Cells are assigned to clusters based on the largest
posterior probability. For each cluster, the cluster mean of Ẽi is treated as the cluster
center. Instead of using the cluster number determined by mclust based on BIC, users
also have the option to specify their own cluster number.
2.2.4 Ordering cell clusters by MST
Next, TSCAN constructs a minimum spanning tree to connect all cluster centers. In
a connected and undirected graph, a spanning tree is a subgraph that is a tree and
connects all the vertices (or “nodes”). Suppose each edge in the graph has a length
equal to the Euclidean distance between the two nodes (i.e., cluster centers) connected
by the edge. A minimum spanning tree (MST) is a spanning tree with the smallest
total edge length among all possible spanning trees. Unlike the MST approach used by
Monocle where the tree is constructed to connect individual cells, the MST in TSCAN
is constructed to connect clusters of cells. Clustering cells reduces the variability and
complexity of the tree space. The cluster level MST therefore may yield better and
more stable estimates of the tree backbone which largely determines the cell ordering.
Another advantage of clustering is that it dramatically reduces the number of tree
nodes, so that it becomes easier for users to interactively fine-tune the analysis later
(e.g., manually adjust the order of tree nodes).
A tree may have multiple branches. By default, we define the main path of the
tree (solid lines in Figure 2-1D) as the path with the largest number of clusters. If
more than one path has the same largest number of clusters, the path with the largest
number of cells becomes the main path. The main path has two ends. Without
other information, one end will be randomly picked up as the origin of the path.
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Alternatively, users can specify one end as the origin themselves using information
such as marker gene expression. After the main path and its origin are determined,
TSCAN will enumerate all branching paths starting from the origin. For instance,
assume cluster 1 in Figure 2-1D is chosen as the origin, then TSCAN will report a
main path 1-2-3-4 and a branching path 1-2-3-5. If the cluster order generated by the
algorithm is not satisfactory to users, they have options to manually specify the paths
and the order of clusters along each path.
2.2.5 Cell ordering and pseudo-time calculation
Once the cluster-level ordering is determined, individual cells are projected onto tree
edges to create cell-level ordering along the main path and each branching path. For
each path, all clusters on the path are collected. All cells in these clusters will be
ordered along the path as follows. Let Ci (i = 1, 2, ...,M) indicate the ordered clusters,
where M is the number of clusters on the ordered path. Suppose Ẽ(i) and Ẽ(j) are the
cluster centers for two neighboring clusters Ci and Cj in the path, and suppose Ci
precedes Cj in the ordering. The edge that connects the two clusters is determined
by vij = Ẽ
(j) − Ẽ(i), and the projection of cell k to the edge is determined by the
inner product vTijẼk/||vij|| where ||.|| is the l2-norm of a vector. Cells in cluster C1
are all projected onto the edge that connects C1 and C2. Cells in cluster CM are all
projected onto the edge that connects CM−1 and CM . Cells from an intermediate
cluster Cm(1 < m < M) are divided into two groups according to whether they
are closer to the center of cluster Cm−1 or to the center of cluster Cm+1 in terms of
Euclidean distances. Cells closer to the center of cluster Cm−1 are projected onto the
edge that connects clusters Cm−1 and Cm, while cells closer to the center of cluster
Cm+1 are mapped to the edge connecting clusters Cm and Cm+1.
Cell orderings are determined in three steps. First, for cells which are in the same
cluster and are projected onto the same edge, their order is determined by the projected
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values on the edge. Second, within each cluster, the order of cells projected onto
different edges is determined by the order of edges, which is given by the cluster-level
ordering. Third, the order of cells in different clusters is determined by the order of
clusters. In this way, all cells can be placed in order.
Once cells are ordered, pseudo-time is computed for each ordered path. For a
given path, the order of a cell on the path is set to be its pseudo-time. For instance,
the pseudo-time for the kth cell on a path is set to k. The pseudo-time is constructed
separately for the main path and each branching path.
2.2.6 Detecting differentially expressed genes
After cells are ordered, one can detect differentially expressed genes following the
approach in Monocle [27]. A generalized additive model (GAM, effective degrees of
freedom = 3) [62] is fitted for each gene to describe the functional relationship between
its expression and pseudo-time. The GAM is fitted using the mgcv [62] package in R.
The model is then compared to a null model that assumes constant expression along
the pseudo-temporal path. The p-value is computed using a likelihood ratio test and
then converted to false discovery rate (FDR) using the method in [63]. By default,
genes with FDR < 0.05 are reported as differential. As in Monocle, the p-value and
FDR are computed based on assuming that cell ordering is given. They do not consider
uncertainties in cell ordering and that, instead of being determined by experiment
design, cell ordering is derived from the same data used for analyzing differential
expression. We note that how to evaluate statistical significance that further accounts
for these additional uncertainties remains an open problem. It requires development
of more sophisticated methods and a systematic investigation of how these additional
uncertainties affect different methods (e.g., how p-values change when one treats cell
ordering as an unknown parameter inferred from the data). These investigations are
beyond the scope of the current study as the main focus of this article is how to
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improve and evaluate cell ordering.
2.2.7 Method evaluation
We use three methods to evaluate cell ordering performance. The first approach
evaluates cell ordering accuracy based on the ordering expected by independent
sources of information. It is assumed that external information not used in pseudo-
time reconstruction is available to evaluate the pairwise order of cells. Formally, let π
denote an ordered path of Nπ cells produced by a particular pseudo-time reconstruction
method. Let g(π, i, j) be a score that characterizes how well the order of the ith and
jth cells in the ordered path π matches their expected order based on the external
information. We define Pseudo-temporal Ordering Score (POS) for cell ordering π as






g(π, i, j) (2.2)
Cell orderings π produced by different pseudo-time reconstruction methods can then
be compared based on the POS score.
As a concrete example, suppose one has single-cell RNA-seq data collected from a
time course experiment. In such an experiment, the data collection time is known.
For the purpose of evaluating unsupervised pseudo-time reconstruction methods, one
can pool cells from all time points together, pretend that the data collection time
for each cell is unknown, and apply different methods to reconstruct pseudo-time.
Different methods will then be evaluated by comparing their cell ordering results to
the order of cells based on the true data collection time. For instance, if one has N
cells collected at V time points during a differentiation process. Among the N cells,
Nv cells are from time Tv (T1 < T2 < · · · < TV ). Consider the ith cell and the jth cell
in the ordered path π where i precedes j (i.e., i < j). One can define the pairwise
score g(π, i, j) as follows:
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1. If the two cells are originally collected at the same time point (e.g., they are
both from Tv), then g(π, i, j) = 0.
2. Otherwise, if the ith cell is collected from time point Tv and the jth cell is
collected from time point Tu, then g(π, i, j) = (u− v)/Dπ. The value u− v is
positive if v represents an earlier time point, or negative if v represents a time
later than u.
The denominator Dπ above is chosen to normalize POS so that POSπ ∈ [−1, 1] (i.e.,
the maximal and minimal POS among all possible orderings of cells within each path
π is 1 and −1 respectively). Based on this definition, a cell ordering more consistent
with the known data collection time will have higher POS score. POSπ = 1 indicates
that the order of cells produced by pseudo-time reconstruction perfectly matches the
order determined by the data collection time. POSπ = −1 indicates that the order of
cells produced by pseudo-time reconstruction is in the opposite direction compared to
the order determined by the data collection time. Using POS to evaluate cell ordering
is based on assuming that the external information (i.e., the true data collection
time in this example) can roughly reflect the true biological order of cells (e.g., the
differentiation stage of cells). In reality, since cells collected at each time point are
heterogeneous, it is possible that some cells collected at an earlier (less differentiated)
time point in the differentiation time course are actually more differentiated than
certain cells collected at a later time point. Despite this, it is often reasonable to expect
that cells collected at the earlier time point “on average” should be less differentiated
than cells collected at the later time point. Therefore, the external information (i.e.,
the data collection time) used here can still roughly reflect the true biological order of
cells and can be used as a surrogate to evaluate the cell ordering performance.
The second approach evaluates robustness of cell ordering by perturbing the original
single-cell RNA-seq dataset (see below). Each cell ordering method is applied to
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both the original dataset and the perturbed data. Cell orderings produced by the
original and perturbed data are then compared. To quantify the similarity between
cell orderings in two pseudo-temporal paths π1 and π2, let A be the union of cells in
π1 and π2, let |A| be the cardinality of A (i.e., the number of distinct cells in π1 and






h(π1, π2, i, j) (2.3)
Here h(π1, π2, i, j) = 1 if the order of two cells i and j remains the same in π1 and π2
(i.e., i appears before or after j in both orderings), and h(π1, π2, i, j) = 0 otherwise.
If either i or j occurs only in one path (e.g., i is in π1 but not π2), the orderings
between i and j in π1 and π2 are viewed as inconsistent, and h(π1, π2, i, j) is also set
to zero. A higher similarity score indicates that the two orderings π1 and π2 are more
similar to each other, whereas a lower score indicates a larger deviation between the
two orderings.
In this article, two different approaches were used to perturb data: cell-level
perturbation and expression-level perturbation. For cell-level perturbation, x percent
(x = 95%, 90% or 75%) of cells were randomly sampled from the original dataset
to serve as the perturbed data. The gene expression profile of each cell remained
unchanged. For expression-level perturbation, we retained all cells in the original
dataset but added simulated noise to their gene expression profiles (i.e., Y). To
generate noise, the average expression value of each gene across all cells was computed
and then subtracted from the gene’s expression value in each cell. Residuals obtained in
this way were scaled by multiplying with a scaling factor κ (κ = 5%, 10% or 25%). The
scaled residuals were then permuted and added back to the original expression values
of the gene. For each perturbation method and parameter value (x or κ), the original
data were independently perturbed 100 times to generate 100 perturbed datasets. For
each perturbed dataset, similarity score between the original and perturbed orderings
was computed. Finally, the average similarity score from the 100 perturbations was
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calculated to measure the robustness of each pseudo-time reconstruction method.
The third approach evaluates the ability of a cell ordering method to detect known
differentially expressed genes along the ordered cell path. Given a test dataset, one
can collect genes known to be differentially expressed along the biologically ordered
sequence of cells and treat them as the gold standard. One can then detect differential
genes along the pseudo-time axis and compare different methods based on how they
rank gold standard genes.
2.2.8 TSCAN package and GUI
TSCAN is implemented as a Bioconductor package using the statistical programming
language R. It can be run both in a command-line mode and through a graphical
user interface (GUI). The GUI is developed using the shiny package in R. It allows
users to conveniently construct, visualize and tune cell ordering. For example, one
can use the GUI to interactively trim unwanted cells based on expression levels of
user-specified marker genes. One can also change the cluster-level ordering and then
recompute the pseudo-time. TSCAN is open source, and it is freely available at
https://github.com/zji90/TSCAN. Its bioconductor package can be downloaded from
http://www.bioconductor.org/packages/release/bioc/html/ TSCAN.html.
2.2.9 Datasets
Three datasets were compiled from the literature to evaluate TSCAN. The first dataset
consists of single-cell RNA-seq samples from differentiating human skeletal muscle
myoblasts (HSMM) [27]. It contains 271 cells collected at 0, 24, 48 and 72 hours
(hrs) after switching human myoblasts to low serum. The second dataset consists of
single-cell RNA-seq samples collected after stimulating bone-marrow-derived dendritic
cells by lipopolysaccharide (LPS) [64]. 306 cells collected at 1, 2, 4 and 6 hrs after the
stimulation were used for our analysis. The third dataset consists of single-cell RNA-
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seq samples from hippocampal quiescent neural stem cells (qNSC) [65]. It contains
172 cells collected from the same cell population. For all datasets, the normalized gene
expression values (fragments per kilo base pairs per million total reads for HSMM
and transcripts per million total reads for LPS and qNSC) were log2 transformed
after adding a pseudo-count of 1. After the raw data Yi were processed to Ei, Ei was
used as input for different methods (i.e., TSCAN, Monocle, Waterfall, SCUBA and
Wanderlust below) to construct pseudo-time. The normalized data for Yi and Ei are
available at the TSCAN GitHub website (https://github.com/zji90/TSCANdata).
2.2.10 Comparisons with other methods
Table 2-I compares TSCAN with a number of other single cell data analysis methods.
Among these methods, MARS-seq [56] and SINCE-PCR [58] do not have associated
software for others to use. SPADE [54] and viSNE [52] are developed for analyzing mass
cytometry or flow cytometry data, and they do not provide a cell ordering function.
Diffusion map [66] is a dimension reduction technique used to define differentiation
trajectories. It cannot perform cell ordering itself. The scLVM method [57] primarily
focuses on identifying cell subpopulations. Again, it cannot order cells. For the
above reasons, these methods are not compared with TSCAN in our subsequent data
analyses.
Among the remaining methods, Monocle is designed to handle unsupervised cell
ordering of single-cell RNA-seq and has a software package. Wanderlust [53] is
originally developed for mass or flow cytometry data. It uses a graph-based trajectory
detection algorithm to order cells under the assumption that there is no branch. We
tailored its MATLAB code to allow it to take single-cell RNA-seq data as input.
SCUBA [55], as discussed before, is a supervised approach. However, the SCUBA
package also provides an option for unsupervised cell ordering which is based on fitting































































































Table 2-I. Comparison of TSCAN and other single cell data analysis methods
analysis pipeline used by [65] to construct pseudo-time for their qNSC data. Similar
to TSCAN, Waterfall first groups cells using k-means clustering before pseudo-time
reconstruction. However, as an in-house data analysis pipeline, Waterfall does not
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have an associated software tool, and the pipeline cannot be directly used to analyze
other datasets without manually editing the code. Also, an objective evaluation of
the effects of cell clustering on cell ordering was not provided in [65]. A systematic
comparison among different pseudo-time reconstruction methods discussed above
is still lacking. In order to benchmark the unsupervised cell ordering performance
of TSCAN, we compared it with Monocle, Wanderlust, unsupervised SCUBA and
Waterfall in our subsequent data analyses.
2.3 Results
We evaluated TSCAN using the three datasets, HSMM, LPS and qNSC, described
above. HSMM and LPS datasets contain cells collected from multiple time points
in time course experiments. The actual data collection time provides important
external information for evaluating cell orderings produced by unsupervised pseudo-
time reconstruction methods. In our evaluation, cells from different time points were
pooled together. We pretended that their data collection time were unknown. We
applied different pseudo-time reconstruction methods to order these cells. Methods
were then compared in terms of their accuracy, robustness and ability to detect
known differentially expressed genes. Accuracy was characterized by the POS score
computed using cells’ actual data collection time. Robustness was characterized by
the cell ordering similarity between the original and perturbed data. In the qNSC
dataset, all cells were collected from the same cell population. Since there was no
external information such as multiple time points to calculate the POS score, we only
evaluated robustness and the ability to detect known differentially expressed genes in
this dataset.
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2.3.1 HSMM analysis using a priori chosen genes for pseudo-
time reconstruction
We first evaluated the performance of TSCAN using the HSMM dataset, originally
analyzed by [27] using Monocle. In the original Monocle analysis conducted by [27], the
pseudo-time was constructed using 518 genes chosen a priori before ordering the single-
cell RNA-seq data. These genes were derived by comparing different differentiation
time points and therefore are known to be associated with myoblast differentiation.
They represent a strong piece of prior knowledge for pseudo-time reconstruction. In
real applications, if one has strong prior information such as these 518 genes, one can
use them as the input (to replace Ei) for TSCAN and Monocle to construct MST.
We first performed analyses in this way by using the same 518 genes for pseudo-time
reconstruction. Figure 2-3A and Figure 2-3B show the cluster-level MST constructed
by TSCAN. Consistent with the original Monocle results reported in [27], TSCAN
also detected two branches of biological process: the default main path 1-3-5-2 and
a branching path 1-3-5-4. For the main path 1-3-5-2, neither Monocle nor TSCAN
can determine whether node 1 or 2 should be the starting time point without other
information. Therefore, the path has two possible directions. By default, TSCAN
randomly picks one direction. However, if users have marker genes to inform the
direction of the pseudo-temporal path, they can use this information in TSCAN.
To illustrate, ENO3 is a marker gene for myoblast differentiation. Its expression is
expected to increase as the differentiation progresses. After providing ENO3 as a
marker gene, TSCAN displays its expression in each tree node. In this way, one
can see that cluster 1 has low ENO3 expression while cluster 2 has high ENO3
expression (Figure 2-3C). Thus, the starting time point should be in cluster 1. As
reported in [27], the branching path in the MST constructed by Monocle was driven
by contaminating interstitial mesenchymal cells, and SPHK1 is a marker gene for
these contaminating cells. Consistent with this, displaying SPHK1 expression in the
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TSCAN tree nodes shows that cluster 4 in the branching path 1-3-5-4 had high SPHK1
expression (Figure 2-3D), indicating that this branch was driven by contaminating
cells. Thus, the branching path 1-3-5-4 was not further analyzed.
Figure 2-3. TSCAN analysis in HSMM dataset using 518 a priori chosen genes for
pseudo-time reconstruction. (A) MST reported by TSCAN is shown in the 3 dimensional
space spanned by the first three principal components (PCs) of E. (B) Users can display
cells and MST in chosen PCs (e.g., PC1 and PC2). (C) Mean expression level of ENO3 in
each cluster. (D) Mean expression level of SPHK1 in each cluster. Values in (C) and (D)
are both standardized across all clusters to have zero mean and unit SD.
For both Monocle and TSCAN, we calculated the POS score along their reported
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main path. According to [27], the main path produced by Monocle in this analysis
corresponds to myoblast differentiation which is the biological process of interest.
Figure 2-4A shows the POS scores. TSCAN outperformed Monocle in terms of the
POS.
In order to understand how cell clustering affects the cell ordering performance,
we tested a modified TSCAN (nocluTSCAN) in which the cell clustering step was
skipped and MST was constructed directly to connect individual cells based on Ẽi.
The analyzed path and direction were then determined as above by using SPHK1 to
exclude the contamination path and using ENO3 to determine the time origin. The
comparison between TSCAN and nocluTSCAN was well-controlled since everything
was the same for these two algorithms except for the use of cell clustering by TSCAN.
By contrast, the performance difference between Monocle and TSCAN represents
a combined effect of many factors since many of their implementation details are
different. Many of these differences are difficult to control for as they are hidden in
the computer code.
We also tested a marker-gene-only approach (marker) in which cells are directly
ordered using the expression level of a marker gene (ENO3). Here, in order to conduct
a relatively fair comparison with TSCAN, the marker-gene-only approach was only
applied to cells from the analyzed TSCAN path (i.e., 1-3-5-2), and cells from the
contaminated TSCAN branch (i.e. the branch with cluster 4) were excluded from
this analysis. The comparison between the marker-gene-only approach and TSCAN
can reveal whether the other genes used for pseudo-time reconstruction contribute
additional information not provided by the marker gene (i.e., ENO3 in this example)
for ordering cells.
As shown by Figure 2-4A, TSCAN had the best performance based on POS. It
not only performed better than Monocle, but also outperformed nocluTSCAN and
the marker-only approach, indicating that cell clustering and using multiple genes for
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ordering cells were both helpful for improving the pseudo-time reconstruction.
Figure 2-4. Evaluation results for different methods in HSMM dataset where pseudo-time
was constructed based on 518 a priori chosen genes. (A) POS score. (B) Robustness
measured by the average similarity score from 100 independent perturbations. The heat
map shows robustness of each method in each perturbation scheme. Cell Perturb: cell-level
perturbation. Expr Perturb: expression-level pertubation. (C) Mean rank of gold standard
genes. (D) Number of detected gold standard genes among top differential genes.
Next, we compared robustness of different methods based on cell ordering similarity
between the original and perturbed data. Figure 2-4B shows the similarity scores
when the perturbed data were generated by randomly subsampling 75%, 90% or 95%
of cells from the original dataset (cell-level perturbation) or by adding 5%, 10% or 25%
random noise to the original gene expression values (expression-level perturbation). For
each perturbed dataset, the same protocol and marker genes as described above were
used to determine the path direction and eliminate contaminating branch. Compared
to Monocle and nocluTSCAN, TSCAN consistently produced higher similarity scores
in all perturbation schemes (Figure 2-4B). This shows that cell clustering increased
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the stability (or equivalently, reduced the variability) of cell ordering when data were
perturbed. The marker-gene-only approach was also more robust than Monocle and
nocluTSCAN, and it showed similar level of robustness compared to TSCAN (Figure 2-
4B). The robustness of the marker gene approach was not unexpected. For cell-level
perturbation, genes’ expression values in each cell did not change. Consequently, the
order of any pair of cells based on a marker gene’s expression remained the same. The
difference between the pseudo-temporal path in the original data and the path in the
perturbed data in the marker gene approach mainly reflects the fact that these two
paths did not contain the same set of cells. Note that not all cells in the original
data were retained in the perturbed dataset. Also, contaminating branches of MST
constructed by TSCAN were excluded from our marker-gene-only analyses, and the
contaminating branches in the original and perturbed data could contain different
sets of cells. For expression-level perturbation, noises added to gene expression values
represented 5-25% of the cross-cell variation of the true biological signal. Consequently,
the pairwise order of many cells was still driven by the biological variation and hence
remained unchanged in the marker-gene-based ordering.
It is important to point out that robustness alone is not sufficient to indicate good
cell ordering performance. For instance, suppose each cell has an arbitrary name. If
cells are ordered based on cell name rather than gene expression profile, the order
of any pair of cells will remain the same regardless of how gene expression values
are perturbed. As a result, the cell ordering is robust, but it does not have any
biological meaning since the cell names are arbitrary. This is similar to the well-known
variance-bias tradeoff in statistics: an estimator with zero variance may have huge
bias. For this reason, robustness of a pseudo-time reconstruction method needs to
be interpreted in the context of whether it leads to improved cell ordering accuracy
(e.g., increased POS score). Although the marker-gene-only approach was more robust
than Monocle and nocluTSCAN (Figure 2-4B), its cell ordering accuracy was lower
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than Monocle and TSCAN (Figure 2-4A), indicating that its bias-variance tradeoff is
not optimal. By contrast, TSCAN was not only more robust (Figure 2-4B) but also
ordered cells more accurately (Figure 2-4A) than Monocle and nocluTSCAN.
For each method, we next detected differentially expressed genes along the ordered
main path of cells. We ranked genes based on FDR, and then different methods were
compared based on their ability to find genes known to be involved in the biological
process in question. For the HSMM dataset, we compiled 13 genes (ENO3 excluded)
known to be involved in myoblast differentiation according to [27]. Figure 2-4C shows
the mean rank of these gold standard genes in the differential gene analysis. A smaller
mean rank indicates better performance (i.e., gold standard genes are more likely to
be ranked on top). Figure 2-4D shows the number of gold standard genes found in
the top 200, 400, . . . , 2000 genes ranked by each method. Monocle and TSCAN had
very similar results in this analysis, and both methods outperformed nocluTSCAN
and the marker gene approach.
Besides TSCAN, we investigated two other ways to perform cell-clustering-based
pseudo-time reconstruction. First, we replaced mclust by k-means clustering in the
cell clustering step of TSCAN while keeping all other procedures the same (k-means
TSCAN). Unlike mclust which allows ellipsoidal shape of clusters, k-means clustering
only allows clusters with circle shape. In order to determine the cluster number of
k-means, we used an approach similar to Figure 2-1E, with its y-axis changed to the
proportion of total data variance unexplained by the cluster structure. Second, we
tested the Waterfall algorithm [65] which also uses k-means to cluster cells before
cell ordering. Waterfall does not provide a way to choose cluster number based on
the data. Its cluster number was fixed to 10 which is the default value in Waterfall
codes. Both the k-means TSCAN and Waterfall produced more robust cell ordering
than Monocle and nocluTSCAN (Figure 2-4B). However, their cell ordering accuracy
did not outperform Monocle and was clearly worse than TSCAN, as indicated by the
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POS score (Figure 4A) and differential gene detection performance (Figure 2-4C,D).
This suggests that although k-means TSCAN and Waterfall reduced the cell ordering
variability, their bias-variance tradeoff was not optimal for improving the cell ordering
accuracy.
We also tested unsupervised SCUBA (i.e., the principal-curve-based SCUBA)
and Wanderlust. For SCUBA, low expression of the marker gene ENO3 was used to
determine the path origin. Wanderlust was run by using the cell with the highest ENO3
gene expression as the path origin (because the lowest ENO3 expression was zero, and
zero occurred in many cells, making the choice of path origin not unique). The cell
ordering reported by Wanderlust was then reversed so that the reversed path had low
ENO3 expression at the beginning and high ENO3 expression at the end. The same
approach was also used in other test datasets below to run the Wanderlust analyses.
For both methods, after cells were ordered, GAM was used to detect differentially
expressed genes as in TSCAN. Both Wanderlust and SCUBA were more robust than
Monocle and nocluTSCAN (Figure 2-4B). However, they both had lower cell ordering
accuracy compared to TSCAN (Figure 2-4A,C,D). In fact, TSCAN produced the
highest POS score (Figure 2-4A) and best differential gene detection performance
(Figure 2-4C,D).
As demonstrated in [27], cell orderings based on pseudo-time may reveal gene
expression patterns that cannot be discovered by bulk gene expression data. MEF2C
and MYH2 are two genes involved in the HSMM differentiation. It is known that
these two genes should have increasing expression during the differentiation, and the
expression of MEF2C should start increasing earlier than the increase of MYH2 [27].
Based on the average bulk gene expression at different time points, it was not clear
that MEF2C had a monotone increasing pattern, nor was it clear which gene started
to increase first (Figure 2-5). By contrast, all single-cell analysis methods tested
here were able to recover the overall increasing pattern of MEF2C and MYH2 along
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their analyzed pseudo-time axes, although in Monocle, k-means TSCAN, Waterfall,
SCUBA and Wanderlust, MEF2C decreased a little before increasing (Figure 2-6).
Compared to the other methods, the temporal expression curves fitted by TSCAN and
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Figure 2-5. Averaged bulk gene expression level for MEF2C and MYH2 in HSMM data.
Based on all the analyses above, TSCAN was the method that provided the
best overall performance. It offered the best cell ordering accuracy among all tested
methods and improved cell ordering robustness compared to methods without using
cell clustering (i.e., Monocle and nocluTSCAN).
2.3.2 HSMM analysis without using a priori chosen genes
for pseudo-time reconstruction
In real applications, the prior information for pseudo-time reconstruction such as the
518 genes used above is not always available. When no such prior information is
available, pseudo-time reconstruction has to rely on all genes in the RNA-seq data.
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To evaluate the performance of TSCAN in such a scenario, we repeated the previous
analysis but constructed pseudo-time without using the 518 a priori chosen genes.
Instead, the Ei used for TSCAN was derived from all genes in the single-cell RNA-seq
data using the protocol described in Methods. We also used Ei instead of Yi as the
input for Monocle, Waterfall, SCUBA and Wanderlust in order to make the method
comparison relatively fair. Of note, the dimensionality of Yi was also beyond the
capacity that the Monocle software was able to handle.
The default main path given by TSCAN (Figure 2-7A, path 3-1-2) contained a
cluster of cells with high expression in SPHK1 (Figure 2-7D), indicating that the main
path was contaminated by interstitial mesenchymal cells and may not reflect myoblast
differentiation. In such a scenario, TSCAN allows users to manually tune the analysis.
For instance, with the GUI, one can conveniently visualize the expression of marker
genes (Figure 2-7B) such as SPHK1 (Figure 2-7D, marker for contamination) and
ENO3 (Figure 2-7E, marker for myoblast differentiation). Since SPHK1 is highly
expressed in cluster 3, we chose to study path 2-1-4 which represents the myoblast
differentiation. According to the increasing ENO3 pattern, one can specify that cluster
2 should be the path origin. Alternatively, one can also manually define a path by
specifying the clusters and their order in the path (Figure 2-7C). In this example,
both ways yielded the same path 2-1-4. Similar to TSCAN, the main path in Monocle
was also contaminated by cells with high SPHK1 expression. However, Monocle does
not provide an interface to help users conveniently incorporate such marker gene
information and tune ordering. Users would need to be experienced in programming in
order to adjust the analysis. In comparison, the TSCAN GUI allows users unfamiliar
with programming to visualize and tune the ordering. Therefore, it lowers the bar for
users to customize the pseudo-time analyses and can save them time and effort.
After using high expression of SPHK1 to exclude the contaminating branch and
using low expression of ENO3 to determine the origin of the pseudo-temporal path
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for each method, different methods were then compared.
In terms of cell ordering accuracy, TSCAN had the highest POS score (Figure 2-8A)
and the best mean rank of gold standard genes (Figure 2-8C) among all methods. It
also had the highest power for detecting the gold standard differential genes (Figure 2-
8D). In terms of robustness, methods based on cell clustering (TSCAN, k-means
TSCAN, Waterfall) were more robust than methods that did not use cell clustering
(Monocle, nocluTSCAN), as shown by the increased similarity scores between the
original and perturbed data (Figure 2-8B).
Besides comparing cell orderings from the original and perturbed data, we also
compared cell orderings constructed using and not using the 518 prior genes. To do
so, similarity score between the cell ordering reported in this section and the ordering
reported in the previous section was computed for each method. Figure 2-9A shows
that TSCAN and the marker gene approach produced higher similarity scores than
other methods, suggesting that they produced the most consistent cell ordering results.
For each method, we also compared the consistency of differentially expressed genes
detected by using and not using the 518 prior genes for pseudo-time reconstruction.
For each analysis (i.e., using or not using the 518 prior genes), we obtained the top R
ranked differential genes. The number of common genes between these two analyses
was then counted and plotted as a function of R in Figure 2-9B. Figure 2-9C shows a
similar analysis with a more stringent definition of common genes. Here, any gene
that did not change in the same direction along the two pseudo-temporal paths (i.e.,
the fitted GAM functions from the two analyses have negative correlation) was not
counted as a common gene even if the gene was identified by both analyses among
their top R genes. After excluding these inconsistent genes from the common gene
list, the number of genes remained in the common gene list was then shown as a
function of R. In both Supplementary Figures 3B and 3C, TSCAN and the marker
gene approach showed higher consistency than the other methods. Compared to the
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marker gene approach, TSCAN cell ordering was more accurate according to the POS
score and differential gene detection performance (Figure 2-8A,C,D). Thus, our results
show that TSCAN can make the ordering results less dependent on the availability of
prior genes and at the same time provide the best accuracy compared to the other
methods.
When comparing the expression patterns of MEF2C and MYH2 along the pseudo-
time axis, Monocle and Wanderlust failed to reveal the temporal order of MEF2C and
MYH2, and the increasing pattern of these genes also became less clear (Figure 2-
10). In Waterfall, MEF2C first decreased and then increased, and the temporal
order of MEF2C and MYH2 was not very clear. By contrast, the other methods
successfully revealed the increasing pattern of MEF2C and MYH2 in this analysis.
Their results also more clearly show that MEF2C increased before the increase of
MYH2 (Figure 2-10).
Overall, our analyses again show that TSCAN produced the most accurate cell
ordering results, and it was more robust than methods without cell clustering.
2.3.3 LPS analysis
For the LPS data, we reconstructed pseudo-time without using strong prior knowledge
such as the 518 a priori chosen genes in the HSMM analysis. The analyses were run
based on Ei which was computed using all genes following the protocol described
in Methods. All methods only found one main path without branching paths. To
determine the direction of the path, we used BCL3 as a marker gene. BCL3 is known
to be involved in the response to viral and bacterial stimulus, and its expression level
is expected to increase after LPS stimulation. Figure 2-2 shows the expression of
this marker gene in the TSCAN GUI. Accordingly, cluster 1 was determined as the
origin of the pseudo-time axis. Comparing different methods based on POS score
again shows that TSCAN had the best accuracy Figure 2-11A, BCL3 was used as the
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marker gene for the marker-gene-only approach). Methods based on cell clustering
(TSCAN, k-means TSCAN, Waterfall) were more robust than those not using cell
clustering (Monocle and nocluTSCAN) (Figure 2-11B). To evaluate different methods
based on differentially expressed genes, we compiled 125 known marker genes (BCL3
excluded) from [64]. Figure 2-11C and Figure 2-11D show the mean rank of these
gold standard genes and the number of gold standard genes found in the top ranked
genes reported by each method respectively. Again, TSCAN outperformed all other
methods.
As a specific example, Figure 2-12 shows the expression level of a gold standard
gene STAT2 for the LPS data [64]. STAT2 expression is expected to increase after
LPS stimulation. One can see that the TSCAN result was most consistent with the
known increasing pattern of STAT2. By contrast, the increasing pattern of STAT2
was much less clear in cell orderings produced by all the other approaches. In Monocle,
nocluTSCAN, k-means TSCAN, Waterfall, SCUBA and Wanderlust, STAT2 first
increased and then decreased. In the marker gene approach, the increasing pattern
was weak compared to the high variability of cells around the fitted curve.
2.3.4 qNSC analysis
Lastly, we compared different methods using the qNSC dataset. This dataset does not
have multiple time points or experimental conditions. A prior gene set for cell ordering
was also not available. We therefore run the analyses based on Ei computed using
all genes as described in Methods. All methods produced one single path without
branches. To determine the path direction, we used FOXG1 as a marker gene. FOXG1
is known to be critically involved in proliferative adult NPCs. Low expression of
FOXG1 was used to indicate the origin of the path.
In the qNSC analysis, the POS score cannot be calculated because external
information such as data collection time is not available. Therefore, we only evaluated
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each method’s robustness and its ability to detect known differential genes. For the
differential gene analysis, 1999 known marker genes (excluding FOXG1) were compiled
from [65] to serve as the gold standard. Once again, methods using cell clustering
(TSCAN, k-means TSCAN, Waterfall) improved robustness of cell ordering compared
to those without using cell clustering (Monocle, nocluTSCAN) (Figure 2-13A). TSCAN
offered the best mean rank of gold standard genes among all methods (Figure 2-13B),
and it also had the highest power for detecting the gold standard differential genes
(Figure 2-13C). Figure 2-14 shows the expression level of a gold standard gene SOX9.
As a down-regulated transcription factor, SOX9 expression is expected to decrease
along the pseudo-time [65]. TSCAN and Waterfall results were consistent with this
known decreasing pattern of SOX9, and the decreasing pattern was most evident in
TSCAN. By contrast, SOX9 expression first increased and then decreased in Monocle,
nocluTSCAN and SCUBA. For k-means TSCAN, SOX9 expression first decreased and
then increased. For the marker-gene-only approach and Wanderlust, SOX9 expression
slightly increased. Overall, TSCAN performed the best among all methods.
2.3.5 The graphical user interface
TSCAN has a GUI. As discussed above, the GUI in TSCAN allows users to visualize
marker genes and tune main paths and cluster-level orderings. Besides these functions,
the GUI also provides multiple trimming criteria for users to efficiently trim unwanted
cells. For example, to exclude cells with high expression in two genes PDGFRA and
SPHK1 in HSMM dataset, one can set up two trimming criteria such as PDGFRA >
1 and SPHK1 > 1 (Figure 2-15A) and TSCAN will exclude cells meeting both criteria
(Figure 2-15B). Finally, the GUI can be used to visualize expression of user-specified
genes along pseudo-time as heat maps. For example, Figure 2-15C visualizes the
expression of two genes CCNA2 and CCNB2 after obtaining the pseudo-time ordering
in HSMM data. Together, these functions make the pseudo-time analyses of single-cell
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RNA-seq data more convenient and user-friendly.
2.4 Discussion
In summary, TSCAN offers a new tool to support pseudo-time analysis of single-cell
RNA-seq data. As demonstrated by our results, this approach robustly provides
competitive performance based on different criteria. By comparing methods using and
not using cell clustering, we have shown that cell clustering is a useful technique for
reducing the variability and improving the accuracy of the MST-based pseudo-time
analysis. Although the cell clustering idea has also been used previously in Waterfall, a
systematic evaluation of the impact of cell clustering on cell ordering was not provided
in the Waterfall study [65]. Besides the development and systematic evaluation of
the TSCAN algorithm, we also developed a GUI for TSCAN. The GUI of TSCAN
provides users with the flexibility to interactively explore and adjust the analysis
results.
In order to evaluate TSCAN and other unsupervised pseudo-time reconstruction
methods, we used two time course datasets with multiple time points, HSMM and
LPS, and intentionally avoided using any information on data collection time in our
pseudo-time analyses. In this way, the data collection time can provide an independent
source of information for evaluating the accuracy of cell ordering via POS score. Such
an evaluation cannot be done if the test dataset has only one time point. This explains
why we used HSMM and LPS for evaluation even though in principle such data
could be analyzed in other ways. For instance, one could perform supervised rather
than unsupervised analysis to order cells. Alternatively, one could perform an initial
analysis to identify differentially expressed genes between different data collection time
points and then use them as prior genes (similar to the 518 prior genes for HSMM) to
order cells. Unlike the HSMM and LPS data, the qNSC dataset represents a different
situation faced by many investigators. Here, single-cell RNA-seq data are collected
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from only one biological condition rather than from multiple time points or conditions.
In such a scenario, supervised methods that use data collection time information
to order cells cannot be applied, and one cannot compare different time points or
conditions to find differential genes and use them as prior genes for cell ordering. It is
therefore important to be able to perform unsupervised pseudo-time analysis such as
TSCAN.
Besides TSCAN, this chapter also introduced several methods to quantitatively
evaluate cell ordering performance. We expect that these evaluation methods will
continue to be useful in the future for evaluating other pseudo-time reconstruction
algorithms. Although TSCAN was tested using RNA-seq, in principle it should not
be difficult to tailor this approach to other data types should single-cell data for those
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Gene ● MEF2C MYH2 ENO3
Figure 2-6. MEF2C and MYH2 expression patterns in HSMM dataset where pseudo-time
was constructed based on 518 a priori chosen genes. MEF2C and MYH2 expression in
each cell is plotted as a function of cell order on the analyzed pseudo-time axis. The curves
are the fitted GAM function. The dashed curve is the GAM fit for ENO3, the marker used
to determine the path direction.
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Figure 2-7. Demonstration of GUI and TSCAN analysis of HSMM data using all genes
for pseudo-time reconstruction. (A) MST constructed by TSCAN using all genes. (B)
Users can choose a marker gene in GUI to visualize its expression. (C) Users can define a
path by specifying the clusters to include and their ordering. (D) The average expression
of SPHK1 in each cluster. (E) The average expression of ENO3 in each cluster.
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Figure 2-8. Evaluation results for different methods in HSMM data where pseudo-time
was constructed using all genes. (A) POS score. (B) Robustness measured by the average
similarity score from 100 independent perturbations. (C) Mean rank of gold standard
genes. (D) Number of detected gold standard genes among top differential genes.
42
Figure 2-9. Comparing the cell ordering constructed using 518 prior genes and the cell
ordering obtained without using these genes in the HSMM dataset. (A) Similarity score
between the two orderings for each method. (B) The number of common genes among
the top R differentially expressed genes detected by the two cell orderings is plotted as
a function of R. (C) The number of common genes with consistent change directions
among the top R differentially expressed genes detected by the two cell orderings is plotted
as a function of R. In order to determine if a gene has consistent change direction in the
two cell orderings, the fitted GAM functions of the gene from the two cell orderings are
compared as follows. First, the pseudo-time axes for both cell orderings are linearly scaled
to interval [0,1], and the GAM functions are scaled accordingly. Next, values of the GAM
functions are extracted at 100 evenly spaced pseudo-time points (i.e., 0.01, 0.02, ..., 1),
and then the Pearson’s correlation between the two extracted vectors (representing the two
GAM functions) is computed. Genes with negative correlation are viewed as inconsistent
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Gene ● MEF2C MYH2 ENO3
Figure 2-10. MEF2C and MYH2 expression patterns in HSMM dataset where pseudo-
time was constructed using all genes. The expression of each gene in each cell is plotted
as a function of cell order on the pseudo-time axis. The solid curves are the fitted GAM
function. The dashed curve is the GAM fit for ENO3, the marker gene used to determine
the path direction.
44
Figure 2-11. Evaluation results for different methods in LPS dataset. (A) POS score. (B)
Robustness measured by the average similarity score from 100 independent perturbations.
(C) Mean rank of gold standard genes. (D) Number of detected gold standard genes
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Figure 2-12. STAT2 expression patterns in LPS dataset. STAT2 expression in each cell
is plotted as a function of cell order on the pseudo-time axis. The orange curve is the
fitted GAM function.
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Figure 2-13. Evaluation results for different methods in qNSC dataset. (A) Robustness
measured by the average similarity score from 100 independent perturbations. (B) Mean
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Figure 2-14. SOX9 expression patterns in qNSC dataset. SOX9 expression in each cell is




















































































































































































































































































































































































































































































































Figure 2-15. Further demonstration of TSCAN GUI. (A) Users can set up trimming
criteria by choosing gene names and specifying expression cutoffs. (B) TSCAN excludes
cells that meet all trimming criteria. (C) Users can also visualize the expression of specified




Extraction and Enhancement with
SCATE
3.1 Introduction
A cell’s regulome, defined as the activities of all cis-regulatory elements (CREs) in its
genome, contains crucial information for understanding how genes’ transcriptional ac-
tivities are regulated in normal and pathological conditions. Conventionally, regulome
is measured using bulk technologies such as chromatin immunoprecipitation coupled
with sequencing (ChIP-seq [11]), DNase I hypersensitive site sequencing (DNase-seq [7])
and assay for transposase-accessible chromatin followed by sequencing (ATAC-seq [8]).
These technologies measure cells’ average behavior in a biological sample consisting
of thousands to millions of cells. They cannot analyze each individual cell. When
a heterogeneous sample (e.g., a tissue sample) consisting of multiple cell types or
cell states is analyzed, these bulk technologies may miss important biological signals
carried by only a subset of cells.
Recent innovations in single-cell genomic technologies make it possible to map
regulomes in individual cells. For example, single-cell ATAC-seq (scATAC-seq [32, 33])
and single-cell DNase-seq (scDNase-seq [14]) are two technologies for analyzing open
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chromatin, a hallmark for active cis-regulatory elements, in single cells. Single-cell
ChIP-seq (scChIP-seq [34]), on the other hand, allows single-cell analysis of histone
modification. Technologies for simultaneously mapping open chromatin along with
other -omics modalities are also under active development (e.g., scNMT-seq [67], Pi-
ATAC [68], sci-CAR [35]). These single-cell technologies enable scientists to examine
a heterogeneous sample with an unprecedented cellular resolution, allowing them to
systematically discover and characterize unknown cell subpopulations.
Among the existing single-cell regulome mapping technologies, scATAC-seq is
the most widely used one due to its relatively simple and robust protocol and its
unparalleled throughput for analyzing a large number of cells. It is adopted by the
Human Cell Atlas (HCA) Consortium as a major tool for characterizing regulatory
landscape of human cells ([69]).
Data produced by scATAC-seq are highly sparse. For instance, a typical human
scATAC-seq dataset contains 102–104 cells and 103–105 sequence reads per cell. How-
ever, the number of CREs in the genome far exceeds 105. Thus, in a typical cell, most
CREs do not have any mapped read. For CREs with reads, the number of mapped
reads seldom exceeds two (Figure 3-1A,B) because each locus has no more than two
copies of assayable chromatin per cell in a diploid genome. Also, existing single-cell
regulome mapping technologies including scATAC-seq destroy cells during the assay.
Thus, they only get a snapshot of a cell at one time point. However, molecular events
such as transcription factor (TF)-DNA binding and their dissociation are temporal
stochastic processes. The steady-state activity of a CRE in a cell is determined by
the probability that such stochastic events occur over time. Since probability is a
continuous measure, the overall activity of a CRE in a cell should be a continuous
signal in principle. The sparse and nearly binary scATAC-seq data collected for
each CRE at one single time point therefore cannot accurately describe the CRE’s
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Figure 3-1. Background and motivation. (A)-(D): an example genomic region showing
chromatin accessibility in GM12878 and K562 measured by different methods including
(A) bulk DNase-seq, (B) scATAC-seq from one single cell, (C) scATAC-seq by pooling 100
cells, (D) SCATE-reconstructed scATAC-seq signal from one single cell. (E): Illustration of
CRE-specific baseline activities using the same genomic region. Bulk DNase-seq data from
multiple different cell types show that some loci tend to have higher activity than others
regardless of cell type (e.g. compare the two loci in blue boxes). (F): At the individual CRE
level, the correlation between the log-normalized scATAC-seq read count in one GM12878
cell and the log-normalized bulk GM12878 DNase-seq signal is low (Pearson correlation =
0.394). Each dot is a CRE. (G): After aggregating multiple CREs based on co-activated
CRE pathways by SCRAT, the correlation between the CRE pathway activities in one
GM12878 cell and the bulk GM12878 DNase-seq signal (both at log-scale) is substantially
higher (Pearson correlation = 0.696). Each dot is a CRE pathway.
The discrete, sparse and noisy data pose significant data analysis challenges.
Conventional methods developed for bulk data cannot effectively analyze single-cell
regulome data [70, 71]. As a result, there is a pressing need for new computational
tools for single-cell regulome analysis. Recently, several single-cell regulome analysis
methods have been developed. They can be grouped into three categories based on
52

























chromVAR ✓ C Cluster cells, identify TF motifs associ-
ated with differential accessibility and
variability
[70]
SCRAT ✓ C Cluster cells, identify CRE pathways
associated with differential accessibil-
ity
[71]
BROCKMAN ✓ B Summarize data by k-mers and per-
form principal component analysis on
k-mer features to identify co-varying
TFs, cluster cells
[72]
Dr.seq2 ✓ C Cluster cells, identify peaks (MACS) in
each cell subpopulation
[73]
Cicero ✓ B Identify correlated pairs of CREs [74]
Scasat B Cluster cells, identify peaks (MACS),
differential accessibility analysis
[75]
Destin B Cluster cells [76]
scABC C Cluster cells [77]
PRISM B Quantify cell-to-cell variation to iden-
tify hyperor hypo-variable genomic fea-
tures
[78]
cisTopic B Represent data using low-dimensional
topiccell and region-topic representa-
tion, cluster cells and CREs accord-
ingly
[79]
Table 3-I. Comparison of single-cell regulome analysis methods
Methods in category 1, including chromVAR [70], SCRAT [71] and BROCKMAN
[72], tackle sparsity by aggregating reads from multiple CREs. Instead of analyzing
each CRE, they combine reads from CREs that share either a TF binding motif,
a k-mer, or a co-activation pattern in DNase-seq data from the Encyclopedia of
DNA Elements (ENCODE) [80, 81]. The aggregated data on motifs, k-mers, or
co-activated CRE pathways are then used as features to cluster cells or characterize
cell heterogeneity. To demonstrate the effect of combining CREs, Figure 3-1F shows
chromatin accessibility in cell line GM12878 computed using non-aggregated data at
each individual CRE, and Figure 3-1G shows accessibility computed using SCRAT
aggregated data (i.e., average normalized read count across CREs) for each co-activated
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CRE pathway. After aggregation, the signal in scATAC-seq became more continuous
and showed higher correlation with the bulk DNase-seq-measured accessibility. One
major drawback of aggregating multiple CREs is the loss of CRE-specific information.
Thus, existing methods in this category do not analyze the activity of each individual
CRE.
Methods in category 2, including Dr.seq2 [73] and Cicero [74], tackle sparsity
by pooling multiple cells. Dr.seq2 [73] pools cells and applies MACS [82] to the
pooled pseudobulk sample to call peaks. Cicero [74] first pools the binary chromatin
accessibility profiles from similar cells to create pseudobulk samples. It then uses the
pseudobulk samples to study the pairwise correlation among different CREs. Typically,
scATAC-seq data pooled from multiple cells are more continuous than data from a
single cell, and the pooled data also correlate better with bulk data (Figure 3-1 A-C).
Despite this, pooling cells does not fully eliminate sparsity, particularly in a rare
cell type with only a few cells. Also, pooling cells may result in loss of cell-specific
information. Thus, one may want to only pool cells that are highly similar in order
to better characterize a heterogeneous cell population. This could result in grouping
cells into many small cell clusters, each with only a few highly similar cells. In that
situation, pooling cells alone may not be enough for removing sparsity and accurately
estimating activities of individual CREs.
Methods in category 3 directly work with the peak-by-cell read count matrix or
its binarized version. For example, Scasat [75] converts the peak-by-cell read count
matrix into a binary accessibility matrix and uses this binary matrix to cluster cells.
Destin [76] applies weighted principal components and K-means clustering to the
binary accessibility matrix to cluster cells. scABC [77] uses the read count matrix
to cluster cells via a weighted K-medoids clustering algorithm. PRISM [78] uses the
binary accessibility matrix to compute cosine distance between cells and then uses
this distance to evaluate the degree of heterogeneity of a cell population. CisTopic
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[79] models the binary accessibility matrix using Latent Dirichlet Allocation (LDA).
This approach views each cell as a mixture of multiple topics, and each topic is a
collection of peak regions and their usage preferences. The topic-cell and region-topic
vectors provide a low-dimensional representation of the data. Cells and peaks are then
clustered in this low-dimensional space. Category 3 methods typically are designed
for specific tasks such as clustering and assessment of sample variability rather than
estimating activities of individual CREs.
In summary, while existing methods provide tools for clustering cells, identifying
co-accessible CREs, and analyzing sample heterogeneity, they do not address the
fundamental issue of accurately reconstructing activities of each individual CRE using
sparse data. Knowing activities of each individual CRE is crucial for functional
studies. For example, such knowledge can be used to inform the selection of CREs for
knock-out or transgenic experiments. In order to facilitate accurate reconstruction
of CRE activities using scATAC-seq data, this article introduces a new statistical
and analytical framework SCATE (Single-Cell ATAC-seq Signal Extraction and
Enhancement). SCATE employs a model-based approach to integrate three types of
information: (1) co-activated CREs, (2) similar cells, and (3) publicly available bulk
regulome data. Unlike the existing methods that either aggregate CREs (category
1) or cells (category 2) but not both, SCATE combines both types of information.
SCATE also uniquely uses public regulome data to enhance the analysis and adaptively
optimizes the analysis resolution based on the available information in the scATAC-seq
data. SCATE is freely available as an open source R package via GitHub. Compared
to the existing methods, SCATE can more accurately predict CRE activities and
transcription factor binding sites using the sparse data from a single cell (Figure 3-1
B,D) or a rare cell type as we shall demonstrate.
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3.2 Methods
3.2.1 Single-cell ATAC-seq data preprocessing
Single-cell ATAC-seq data for GM12878 and K562 cells were obtained from GEO
(GSE65360) [32]; Single-cell ATAC-seq data for human hematopoietic cell types
were obtained from GEO (GSE96769) [83]; Single-cell ATAC-seq data for mouse
brain and thymus were obtained from GEO (GSE111586) [84]. For each cell, paired-
end reads were trimmed using the program provided by [32] to remove adaptor
sequences. Reads were then aligned to human (hg19) or mouse (mm10) genome
using bowtie2 with parameter -X2000. This parameter retains paired reads with
insertion up to 2000 base pairs (bps). PCR duplicates were removed using Picard
(http://broadinstitute.github.io/picard/).
3.2.2 Genome segmentation
Genome is segmented into 200 base pair (bp) nonoverlapping bins. Bins that overlap
with ENCODE blacklist regions are excluded from subsequent analyses since their
signals tend to be artifacts [85].
3.2.3 Bulk DNase-seq database (BDDB)
SCATE borrows information from large amounts of publicly available bulk DNase-seq
data to improve scATAC-seq analysis. We compiled a database consisting of 404
human and 85 mouse DNase-seq samples obtained from the ENCODE. Take human
as an example, we downloaded all ENCODE DNase-seq samples generated by the
University of Washington [80] in bam format. Files marked by ENCODE as low quality
(marked as “extremely low spot score” or “extremely low read depth” by ENCODE)
were filtered out. Technical replicates for each distinct cell type or tissue were merged
into one sample. This has resulted in 404 DNase-seq samples representing diverse cell
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types. Mouse samples were processed similarly.
3.2.4 Compiling cis-regulatory elements (CREs) using bulk
data compendium
Given a species and a compendium of bulk regulome samples (e.g., DNase-seq samples
in BDDB), SCATE systematically identifies CREs in the genome as follows. Let yi,j
denote the raw read count of bin i in sample j. Let Lj be sample j’s total read count
divided by 108 (i.e., the library size in the unit of hundred million. For example, a
sample with 200 million reads has Lj = 2). We normalize the raw read counts by
library size and log2-transform them after adding a pseudocount 1. This results in
normalized data ỹi,j = log2(yi,j/Lj + 1). Bin i is called a “signal bin” in sample j if
(1) yi,j ≥ 10, (2) ỹi,j ≥ 5, and (3) ỹi,j is at least five times (three times for mouse)
larger than the background signal defined as the mean of ỹi,js in the surrounding
100 kb region. If a bin is a signal bin in at least one bulk sample, it is labeled as a
“known CRE”. In this way, all genomic bins are labeled as either “known CREs” or
“other bins”. 522,173 known CREs for human and 475,865 known CREs for mouse
are identified using our bulk DNase-seq compendium. Locations of these CREs are
stored in SCATE and provided as part of the software package. Saturation analysis
shows that typically a new bulk sample from a new cell type only contributes a small
fraction (0.013 % for human and 0.18 % for mouse) of new CREs to the known
CRE list (Figure 3-3A). In the three benchmark scATAC-seq datasets used in this
article, datasets 1, 2 and 3 would only add 0.050%, 0.0013%, and 0.063% new CREs,
respectively, to our known CRE list. For the human hematopoietic differentiation
dataset used in the last Results section, the scATAC-seq dataset would only add 0.118
% of new CREs to the known CRE list (Figure 3-3B; the calculation was based on
detecting CREs in each cell type separately and then adding the union of all CREs
from all cell types in the scATAC-seq data to the known CRE list). This suggests that
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the majority of a new sample’s regulome can be studied by analyzing the precompiled
known CREs, which can save user’s work on compiling and clustering their own CREs.
In this article, SCATE is demonstrated using our precompiled known CRE list, as
the performance curves and statistics do not change much by adding new CREs from
each scATAC-seq dataset to the analysis.
3.2.5 SCATE model for known CREs in a single cell
Consider scATAC-seq data from one single cell j. Given aligned sequence reads,
SCATE will estimate activities of known CREs first. Let yi,j denote the observed
read count for CRE i (i = 1, . . . , I) in cell j, and let µi,j denote the unobserved true
activity. Our goal is to infer the unobserved µi,j from the observed data yi,j. We
assume the following data generative model with three components.
1. Model for true activity. The unobserved µi,j is modeled as log(µi,j) = mi + siδi,j .
Here mi and si represent CRE i’s baseline mean activity and standard deviation
(SD). They are used to model the locus-specific but cell-type-independent baseline
behavior of each CRE (i.e., the locus effects observed in Figure 3-1E). Since
these locus-specific effects cannot be reliably learned using sparse data or data
from one cell type, we learn them using the bulk data from diverse cell types in
our bulk regulome data compendium (see below). Once they are learned, mi
and si are treated as known. The unknown δi,j describes CRE i’s cell-specific
activity after removing locus effects (i.e., δi,j = log(µi,j)−misi ).
Due to data sparsity, accurately estimating δi,j using the observed data from
only one CRE in one cell is difficult. Thus, we impose additional structure on
δi,js to allow co-activated CREs to share information to improve the estimation.
We group CREs into K clusters based on their co-activation patterns across cell
types (see below). We assume that CREs in the same cluster share the same
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δ. Mathematically, let δj = (δ1,j, . . . , δI,j)T be a column vector that contains
δi,js from all CREs in cell j. Let X be a I × K cluster membership matrix.
Each entry of this matrix xik is a binary variable: xik = 1 if CRE i belongs to
cluster k, and xik = 0 otherwise. Let βk,j denote the common activity of all
CREs in cluster k. Arrange βk,js into a column vector βj = (β1,j, . . . , βK,j)T .
Our assumption can be represented as δj = Xβj. When the cluster number K
is smaller than the CRE number I, imposing this additional structure on δi,j
reduces the number of unknown parameters from I to K. As a result, it increases
the average amount of information available for estimating each parameter.
Note that in our model, two CREs with the same δ can still have different
activities (i.e., different µi,js) because log(µi,j) = mi + siδi,j. In other words,
SCATE allows co-activated CREs to share information through δ, but at the same
time it also allows each CRE to keep its own locus-specific baseline characteristics.
This is an important feature missing in other existing methods.
Another unique feature of SCATE is that we treat the cluster number K as a
tuning parameter and adaptively choose it based on available information to
optimize the spatial resolution of the analysis. Unlike SCATE, other existing
methods aggregate CREs based on known pathways. For them, K is fixed and
the analysis’ spatial resolution cannot be tuned and optimized.
2. Model for technical bias. Since the locus effects mi and si are learned from the
bulk data, we view µi,j as the activity one would obtain if one could measure a
bulk regulome sample (e.g., bulk DNase-seq) consisting of cells identical to cell
j. In scATAC-seq data, µi,j is distorted to become µsci,j due to technical biases in
single-cell experiments (e.g., DNA amplification bias). We model these unknown
technical biases using a cell-specific monotone function hj(.). In other words,
we assume log(µsci,j) = hj(log(µi,j)). We estimate the unknown function hj(.) by
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comparing scATAC-seq data with the bulk regulome data at CREs that show
constant activity across different cell types (see below). Once hj(.) is estimated,
it is assumed to be known.
3. Model for observed read counts. We assume that the observed read count yi,j
is generated from a Poisson distribution with mean Ljµsci,j. Here Lj is the total
number of reads in cell j divided by 108. It is a cell-specific normalizing factor
to adjust for library size.
To summarize, our model assumes:
yi,j ∼ Poisson(Ljµsci,j)
log(µsci,j) = hj(log(µi,j))
log(µi,j) = mi + siδi,j
δj = Xβj
(3.1)
For a fixed cluster number K, we fit the model as follows: (1) use the bulk regulome
data compendium to learn locus effects mi and si; (2) use scATAC-seq data and the
bulk regulome data compendium to learn technical bias function hj(.) which normalizes
scATAC-seq data with the bulk regulome compendium used to learn locus effects; (3)
given mi, si and hj(.), use the observed data y to estimate β which will determine δ
and µ. The estimated µ provides the final estimates for CRE activities.
In order to optimize the analysis’ spatial resolution, SCATE treats the cluster
number K as a tuning parameter. CREs are clustered at multiple granularity levels
corresponding to different Ks. As K increases, the average number of CREs per
cluster decreases. This increases spatial resolution because the cluster activity more
resembles the activity of individual CREs. However, increasing K also decreases
the amount of information for estimating the activity of each cluster, and thus the
estimates become noisier. We use a cross-validation approach to choose the optimal
K that balances spatial resolution and estimation uncertainty (see below).
60
3.2.6 Estimate locus effects mi and si
We estimate locus effects using the rich bulk data from diverse cell types in the bulk
regulome compendium. Let yi,j be the observed read count for genomic bin i and bulk
sample j (j = 1, . . . , J). Lj represents sample j’s library size in the unit of hundred
million. For each genomic bin i, locus effects are estimated using the observed counts
{yi,j : j = 1, . . . , J}. We model yi,j in bulk data as:
yi,j ∼ Poisson(Ljµi,j)
log(µi,j) = mi + siδi,j
(3.2)
This is similar to the single-cell model above but without the technical bias
component. Without additional constraints, mi and si are not identifiable since each
bin i has only J observed data points but J+2 unknown parameters (i.e., mi, si, and J
different δi,js). Thus, we further assume δi,j ∼ N(0, 1). This is equivalent to assuming
that log(µi,j) for bin i is normally distributed, and mi and si are its mean and SD
respectively. This assumption is based on observing that CREs’ log-normalized read
counts after standardization (i.e. subtract mi and divide by si) are approximately
normally distributed (Figure 3-2). With this additional constraint, mi and si become
identifiable. Since maximum likelihood estimation for all genomic bins in a big genome
like human is computationally slow, SCATE employs the method of moments to
estimate mi and si. Based on the model and theoretical moments of Poisson and






























By matching the model-based moments to the empirical first two moments of the
observed yi,j/Ljs, we obtain the following closed-form estimates for mi and si which


















Figure 3-2. The empirical distribution (histogram) of the log-normalized read counts in
human BDDB after standardization (i.e., subtract the mean and divide by SD of each






























3.2.7 Estimate technical bias function hj(.)
The cell-specific technical bias function hj(.) is estimated using known CREs whose
activities do not change much across cell types. All known CREs are sorted according
to s̃i estimated above which reflects their variability across diverse cell types in the
bulk regulome data compendium. We split m̃i into ten groups by its 10%, 20%, ...,
100% quantiles, and find 1000 CREs with the smallest s̃i in each group. The union set
of these 10000 CREs is a set H of “low-variability” CREs. For these low-variability
CREs, their activities are almost constant across cell types. Thus, one can assume
that their activities in a new cell are known and approximately equal to m̃i, and the
model for their scATAC-seq read counts in a new cell j can be simplified to:
yi,j ∼ Poisson(Ljµsci,j)
log(µsci,j) = hj(log(µi,j)) ≈ hj(m̃i)
(3.6)
We estimate hj(.) using yi,js from these low-variability CREs. The function hj(.) is
monotonically increasing but has unknown form. We model it using monotone spline
[86] (splines2 package in R):
hj(x) = αj,0 +
T∑︂
t=1
αj,tIt(x) s.t. αj,t ≥ 0 (t = 1, ..., T )
Here It(x) are known I-spline basis functions (which are monotone functions [86])
and αj,ts are unknown regression coefficients. The constraints αj,t ≥ 0 make hj(.)
monotone and non-decreasing. The maximum likelihood estimates for coefficients
αj = {αj,t : t = 0, . . . , T} can then be obtained as:
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[yi,j ∗ h(m̃i) − Ljeh(m̃i)] s.t. αj,t ≥ 0 (t = 1, ..., T ) (3.7)
To select the optimal set of basis functions, we try different settings of knots by
changing T . We set T = 1, 2, ..., 6, respectively, which sets the number of knots from 0
to 5. For each T , the t/T -th quantiles (t = 1, ..., T − 1) of m̃i are chosen as the knots.
Given the knots, the spline basis functions are then generated by splines2. The T
with the smallest Bayesian information criterion (BIC) is chosen to obtain the optimal
set of basis functions.
3.2.8 Estimate β, δ and µ
Once the locus effects mi and si and technical bias function hj(.) are estimated, SCATE
treats them as known and will then estimate β. Suppose CREs are grouped into K
clusters. The activity for cluster k in cell j, βk,j, can be estimated using the observed
read counts in cell j for all CREs in the cluster. When data are sparse (particularly
for clusters with small number of CREs), the maximum likelihood estimate can
be unreliable due to its high variance. Thus, consistent with our bulk regulome
data model, we impose a prior distribution on βk,j to help regularize its estimation:
βk,j ∼ N(0, 1). We then estimate βk,j using its posterior mode:




[yi,jhj(mi + siβ) − Ljehj(mi+siβ)] − β2/2
Here C(k) represents the set of CREs in cluster k. The above optimization involves
only one variable β, and thus the computation is not expensive. Estimation of different
βk,js are handled separately.
Given β̃k,j, δi,j and µi,j can be derived using model (3.1).
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3.2.9 Analysis at multiple spatial resolution levels (i.e., mul-
tiple Ks)
SCATE analyzes data at multiple spatial resolution levels by setting the cluster number
K to different values. To do so, known CREs are clustered based on their co-activation
patterns across all samples in the bulk regulome data compendium. Before clustering,
CREs’ normalized data ỹi,j are organized as a matrix. Rows of the matrix correspond
to CREs and columns correspond to samples. Each row is standardized to have zero
mean and unit SD. Then CREs (i.e., rows) are clustered hierarchically at multiple
granularity levels. A naive hierarchical clustering of 522,173 CREs (475,865 CREs for
mouse) is difficult because it requires computing a distance matrix on the order of
500, 000×500, 000. To make the computation tractable, SCATE employs a three-stage
clustering approach.
• Stage 1: CREs are grouped into 5000 clusters using K-means clustering (Eu-
clidean distance). Each cluster contains approximately 100 CREs that show
similar cross-sample activity patterns. For each cluster, the mean activity of all
CREs in each sample is computed. It is then standardized to have zero mean
and unit SD across samples.
• Stage 2: To obtain coarser clusters, the 5000 clusters from stage 1 are grouped
hierarchically using hierarchical clustering (Euclidean distance, complete agglom-
eration) based on their mean activity profile. In this way, CREs are hierarchically
grouped into 5000, 2500, 1250, 625, 312 and 156 clusters.
• Stage 3: To obtain fine-grained clusters, for each cluster obtained in Stage
1, hierarchical clustering is applied to split CREs in that cluster into smaller
clusters. In this way, each cluster from Stage 1 can be divided into 2, 4, 8, ...
subclusters until each subcluster contains only one CRE.
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CREs’ clustering structure for human and mouse obtained using our DNase-seq
compendium is stored and provided as part of the SCATE package. Users can use it
directly without recomputing them.
3.2.10 Optimizing spatial resolution (K) by cross-validation
SCATE optimizes the spatial resolution of the analysis by choosing the optimal K via
cross-validation. For a given K, after clustering CREs, CREs are randomly partitioned
into a training set (90% CREs) and a testing set (10% CREs). Next, for each cluster
k, CREs in the training set are used to estimate βk,j which is the common activity of
all CREs in that cluster. Using the estimated β̃k,j, the log-likelihood of the test CREs
in cluster k can be computed according to model (3.1) because they share the same
βk,j with training CREs in the same cluster. We perform the same calculations for all
clusters and obtain the median log-likelihood of all testing CREs.
The above procedure is run for different values of K. The cluster number K with
the largest median log-likelihood in test data is selected as the optimal K.
3.2.11 Postprocessing – SCATE for other genomic bins in a
single cell
After estimating activities of known CREs, SCATE will analyze all other bins in the
genome. These bins fall into two classes. First, some bins have zero scATAC-seq
read count across all cells. For these bins, µi,j is estimated to be zero. Second, the
remaining bins have at least one read in the scATAC-seq data. For these bins, we
estimate µi,j using a predictive machine learning approach xgboost (eXtreme Gradient
Boosting [87]) where the response variable is the SCATE signal µ̃i,j and the predictors
are normalized read count yi,j/Lj , mi and si. The model is trained using known CREs.
The trained model is then applied to bins not included in the known CRE list to make
predictions. This will transform the read counts at these bins to a scale consistent
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with the reconstructed activities for known CREs.
3.2.12 SCATE for multiple cells
When a scATAC-seq dataset contains multiple cells, we first cluster cells using a
method similar to our previously published method SCRAT [71]. Before clustering
cells, CREs are grouped into 5000 clusters using BDDB as before. For each cell, the
average activity of all CREs in each CRE cluster is calculated as in SCRAT. This
transforms the scATAC-seq data in each cell into a feature vector consisting of 5000
CRE cluster activities. After quantile normalizing features across cells, features with
low-variability across cells are filtered out. To identify low-variability features, for
each feature we calculate the mean and SD of its activity across cells. Using the means
and SDs of all features, we fit a polynomial regression with degree=3 to describe the
relationship between the SD (response) and mean (independent variable). Features for
which the observed SD is smaller than the expected SD (from the fitted model) given
the mean activity are filtered out. Among the remaining high-variability features,
we retain those that have non-zero read count in at least 10% of cells. PCA is then
performed on the retained features. The top 50 principal components are then used
to perform tSNE. The model-based clustering (mclust in R) [60] is used to perform
clustering on tSNE space with default settings. The cluster number is chosen based on
the Bayesian Information Criterion in mclust. If users do not want to use the default
cluster number or clustering method, SCATE also provides an option to allow them
to specify the cluster number by their own or use their own clustering results from
other algorithms.
After cell clustering, each cluster consists of a set of similar cells and represents a
relatively homogeneous cell subpopulation. SCATE will estimate the regulome profile
of each cluster. For each cluster, reads from all cells are pooled together to create a
pseudo-cell. The SCATE model for a single cell described above is then applied to the
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pseudo-cell to estimate CRE activities. The estimated regulome profile of the pooled
sample typically will achieve higher spatial resolution than a single cell since (1) the
pseudo-cell contains data from more than one cell and (2) SCATE automatically tunes
the spatial resolution based on available information. The output of SCATE is the
estimated regulome profile for each cell subpopulation.
3.2.13 Peak calling and evaluation
A moving average approach is used to call peaks from the reconstructed regulome
profile. Given a moving window size 2W + 1, the moving average signal for each 200
bp bin is calculated as the average signal of the bin and its 2W neighboring bins (W
bins on the left and W bins on the right). By default, W = 1 which amounts to
averaging signals from 3 bins spanning 600 bp in total. In parallel, we also calculate
the average signal of 2W + 1 randomly selected bins (not necessarily neighboring bins)
for 100000 times to construct a background distribution for the moving average signal.
For a genomic bin with moving average signal s, the false discovery rate (FDR) is
estimated as the proportion of background distribution larger than s divided by the
observed proportion of genomic bins with signals larger than s. Genomic bins with
FDR smaller than 0.05 are identified and consecutive bins are merged into peaks.
Peaks are ranked by FDR. For peaks tied with the same FDR, they are ranked further
by the moving average signals.
For evaluation, peaks called using signals constructed by different methods are
compared with peaks called using bulk regulome data. In the evaluation, we also




TF motifs are downloaded from JASPAR [88]. These motifs were mapped to the
genome using CisGenome with likelihood ratio cutoff = 100. Narrow peak files of the
corresponding ChIP-seq data in GM12878 and K562 are downloaded from ENCODE.
For each TF and cell type, genomic bins with motif were ranked based on reconstructed
scATAC-seq signals to predict TFBSs. Genomic bins with motif that overlap with
ChIP-seq peaks are used as gold standard.
3.2.15 Processing of benchmark bulk DNase-seq and ATAC-
seq data
The benchmark bulk DNase-seq data for GM12878 and K562 (Dataset 1) are obtained
from ENCODE. Bulk ATAC-seq data for human CMP and monocytes (Dataset 2)
and human hematopoietic cell types in the last example are obtained from GEO under
accession GSE74912. Bulk DNase-seq data for mouse brain and thymus (Dataset 3)
are obtained from ENCODE.
Bulk DNase-seq samples are processed using the same protocol as DNase-seq data
processing in BDDB. For ATAC-seq sample, reads are aligned to human genome hg19
using bowtie with parameters (-X 2000 -m 1). PCR duplicates are removed by Picard
(http://broadinstitute.github.io/picard/). The aligned reads are used to obtain bin
read counts.
3.2.16 Software
SCATE is freely available as an open source R package via GitHub and licensed under
the MIT License:
https://github.com/zji90/SCATE
In terms of computational time, compiling CREs and clustering CREs typically
take 1-2 days. Given the CRE list and CREs’ clustering structure, running SCATE to
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reconstruct regulome approximately takes 5 minutes per cell cluster on a computer
with 10 computing cores (2.5 GHz CPU/core) and a total of 20GB RAM.
3.3 Results
3.3.1 SCATE model for a single cell
SCATE begins with compiling a list of candidate CREs and grouping co-activated
CREs into clusters. Currently, most scATAC-seq data are generated from human
and mouse. For user’s convenience, for these two species we have constructed a Bulk
DNase-seq Database (BDDB) consisting of normalized DNase-seq samples from diverse
cell types generated by the ENCODE project. For each species, we compiled putative
CREs using BDDB and clustered these CREs based on their co-activation patterns
across BDDB samples. Users may augment these precompiled CRE lists by using
SCATE-provided functions to (1) add and normalize their own bulk and pseudo-bulk
(obtained by pooling single cells) DNase-seq or ATAC-seq samples to BDDB and then
(2) re-detect and cluster CREs using the updated BDDB. These functions can also
be used to create CRE database for other species. For human and mouse, saturation
analyses show that BDDB covers most CREs one would discover in a new DNase-seq
or ATAC-seq dataset. On average, a new sample only contributes <0.2% new CREs to
our precompiled CRE lists (Figure 3-3). Thus, in order to save time and computation
for CRE detection and clustering, users may directly use the precompiled CRE lists
in BDDB without significant loss. In this article, our analyses using SCATE are all
carried out using these precompiled CREs as the input.
Given a list of CREs, their clustering structure, and scATAC-seq data from a
single cell, the SCATE model contains the following key components (Figure 3-4A).
(1) Modeling a CRE’s cell-independent but CRE-specific baseline behavior using









































































Figure 3-3. Saturation analysis of BDDB CRE lists. (A): As one increases the number of
DNase-seq samples in the BDDB database, the proportion of new CREs contributed by
adding a new sample gradually decreases. (B): The scATAC-seq datasets analyzed in this
study would only add 0.0013%-0.118% new CREs to the precompiled CRE list in BDDB.
DNase-seq data, we found that these bulk data contain invaluable information not
captured by the sparse single-cell data. In particular, our recent analysis of DNase-seq
data from diverse cell types shows that different CREs have different baseline activities
[89]. Some CREs tend to have higher activity levels than others regardless of cell type
(Figure 3-1E: compare two CREs in blue boxes). As a result, the mean DNase-seq
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Figure 3-4. SCATE overview. (A): SCATE model for a single cell. (B): SCATE model
for multiple cells.
profile across diverse cell types to a large extent can predict the DNase-seq profile
in a new cell type, even though such prediction is cell-type-invariant and cannot
capture cell-type-specific CRE activities. In [89], we found that the mean DNase-seq
profile correlates well with independently measured TF binding activities, indicating
that differences in the baseline activity among different CREs captured by the mean
DNase-seq profile are real biological signals rather than technical artifacts. These
highly reproducible CRE-specific baseline activities cannot be captured by the sparse
data in a single cell or by pooling a small number of cells (Figure 3-1B,C,E). Thus,
in order to better reconstruct activities of each individual CRE from scATAC-seq,
SCATE explicitly models these cell-type-invariant but CRE-specific baseline behaviors
by fitting a statistical model to the large compendium of bulk DNase-seq data in
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BDDB. This allows us to estimate the baseline mean activity (mi) and variability (si)
of each CRE i.
(2) Modeling a CRE’s cell-dependent activity by borrowing information from similar
CREs. We model the activity of CRE i in cell j, denoted as µi,j, by decomposing
it into two components: a cell-type invariant component that models the baseline
behavior (mi and si), and a cell-dependent component δi,j for modeling the CRE’s
cell-specific activity. In other words, log(µi,j) = mi + siδi,j. The cell-type invariant
component is learned from BDDB as described above. The cell-dependent component
is learned using scATAC-seq data in each cell. To do so, we leverage CREs’ clustering
structure. Recall that co-activated CREs are grouped into clusters. We assume that
CREs in the same cluster have the same δi,j. Thus, information is shared across
multiple co-activated CREs. Unlike other methods, we only share information through
δi,j rather than assuming that µi,j is the same across similar CREs. In our approach,
two CREs in the same cluster have the same δ, but they can have different activities
(i.e., different µs) because of the difference in their CRE-specific baseline behaviors.
(3) Bulk and single-cell data normalization. Since CREs’ baseline characteristics
are learned from bulk DNase-seq data but our goal is to model scATAC-seq data, we
need to reconcile differences between these two technologies. To do so, we assume that
µi,j is the unobserved true activity of CRE i in cell j one would obtain if one could
measure a bulk DNase-seq sample consisting of cells identical to cell j. In scATAC-seq
data, µi,j is distorted to become µsci,j due to technical biases in scATAC-seq compared
to bulk DNase-seq. These unknown technical biases are modeled using a cell-specific
monotone function hj(.) such that log(µsci,j) = hj(log(µi,j)). The observed scATAC-seq
read count data are then modeled using Poisson distributions with mean Ljµsci,j where
Lj is cell j’s library size. The technical bias function hj(.) normalizes scATAC-seq
and bulk DNase-seq data. We developed a method to estimate this unknown function
by using CREs whose activities are nearly constant across diverse cell types in BDDB.
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Once hj(.) is estimated, CRE activities δi,j and µi,j can be inferred by fitting the
SCATE model to the observed read count data.
(4) Adaptively optimizing the analysis resolution based on available data. In order
to examine the activity of each individual CRE, ideally one would hope to pool as few
CREs as possible. However, when data are sparse, pooling too few CREs will lack the
power to robustly distinguish biological signals from noise. Thus, the optimal analysis
should carefully balance these two competing needs. All existing methods reviewed in
category 1 pool CREs based on fixed and predefined pathways (e.g., all motif sites of
a TF binding motif). They do not adaptively tune the analysis resolution based on
the amount of available information. In SCATE, co-activated CREs are grouped into
K clusters. Information is shared among CREs in the same cluster. We uniquely treat
K as a tuning parameter and developed a cross-validation procedure to adaptively
choose the optimal K based on the available data. When the data is highly sparse,
SCATE will choose a small K so that each cluster contains a large number of CREs.
As a result, the activity of a CRE will be estimated by borrowing information from
many other CREs. This sacrifices some CRE-specific information in exchange for
higher estimation precision (i.e., lower estimation variance). When the data is less
sparse and more CREs have non-zero read counts, SCATE will choose a large K so
that each cluster will contain a small number of CREs. As a result, the CRE activity
estimation will borrow information from only a few most similar CREs, and more
CRE-specific information will be retained.
(5) Postprocessing. After estimating CRE activities, we will further process all
genomic regions outside the input CRE list. SCATE will transform read counts at
these remaining regions to bring them to a scale normalized with the reconstructed
CRE activities. The transformed data can then be used for downstream analyses such
as peak calling, TF binding site prediction, or other whole-genome analyses.
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3.3.2 SCATE for a cell population consisting of multiple cells
For a homogeneous cell population with multiple cells, we will pool reads from all cells
together to create a pseudo-cell. We will then treat the pseudo-cell as a single cell
and apply SCATE to reconstruct CRE activities. Similar to Dr.seq2, this approach
combines similar cells to estimate CRE activities. Unlike Dr.seq2, we also combine
information from co-activated CREs and public bulk regulome data as described above.
Moreover, SCATE adaptively tunes the resolution for combining CREs (i.e. the CRE
cluster number K) which is lacking in other methods. As the cell number in the
population increases, the sparsity of the pseudo-cell will decrease and the optimal
analysis resolution chosen by SCATE typically will increase.
For a heterogeneous cell population, we first group similar cells into clusters.
SCATE is then applied to each cell cluster to reconstruct CRE activities by treating
the cluster as a homogeneous cell population (Figure 3-4B). By default, SCATE uses
model-based clustering [60] to cluster cells, and the cluster number is automatically
chosen by the Bayesian Information Criterion (BIC). Since one clustering method is
unlikely to be optimal for all applications, we also provide users with the option to
adjust the cluster number or provide their own cell clustering. SCATE can be run
using user-specified cluster number or clustering results. For example, if users believe
that the default clustering does not sufficiently capture the heterogeneity, they could
increase the cluster number. In the most extreme case, if one sets the cluster number
equal to the cell number, each cluster will become a single cell.
We note that pooling cells in each cluster to create a pseudobulk sample does not
mean that the value of single-cell analysis is lost or that scATAC-seq can be replaced
by bulk ATAC-seq or DNase-seq. This is because bulk ATAC-seq or DNase-seq
analysis of a heterogeneous sample cannot separate different cell subpopulations or
discover new cell types. Even if one could use cell sorting to separate cells in a sample
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by cell type and then apply bulk analysis to each cell type, the sorting relies on
known cell type markers and therefore cannot discover new cell types. By contrast, a
scATAC-seq experiment coupled with SCATE can identify and characterize different
cell populations including potentially new cell types in a heterogeneous sample.
3.3.3 Benchmark data
We compiled three datasets for method evaluation. Dataset 1 consists of human
scATAC-seq data from two different cell lines GM12878 (220 cells) and K562 (157
cells) generated by [32]. For this dataset, ENCODE bulk DNase-seq data for GM12878
and K562 were used as the gold standard to evaluate signal reconstruction accuracy.
Dataset 2 contains scATAC-seq data from human common myeloid progenitor (CMP)
cells (637 cells) and monocytes (83 cells) obtained from [83, 90]. We also obtained
bulk ATAC-seq data from human CMP and monocytes generated by [90] and used
them as gold standard. Dateset 3 consists of mouse scATAC-seq data from brain
(3321 cells) and thymus (7775 cells) generated by [84]. For evaluation, the ENCODE
bulk DNase-seq data for mouse brain and thymus were used as gold standard. In all
evaluations, we removed the test cell types from the BDDB before running SCATE in
order to avoid using the same bulk regulome data in both SCATE model fitting and
performance evaluation.
3.3.4 Analysis of a homogeneous cell population - a demon-
stration
We first demonstrate SCATE analysis of a homogeneous cell population using the
GM12878 and K562 data (Dataset 1) as an example. We applied SCATE to each
cell type separately. For each cell type, we randomly sampled n (n = 1, 5, 10, 25,
50, 100, etc.) cells and pooled their sequence reads together to run SCATE. CRE
activities reconstructed by SCATE were compared with their activities measured by
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bulk DNase-seq in the corresponding cell type.
Figure 3-5 shows the normalization function hj(.) learned by SCATE for normalizing
scATAC-seq and the BDDB bulk DNase-seq data. Each scatter plot corresponds to
a pooled scATAC-seq sample. Different plots represent different cell numbers or cell
types. In these plots, each data point is a low-variability CRE with nearly constant
activity across BDDB samples. For each CRE, the read count in the pooled scATAC-
seq sample (Y-axis) versus the CRE’s baseline mean activity in BDDB (X-axis) are
shown. The red curve is the SCATE-fitted function (ehj(.)) for modeling technical
biases in scATAC-seq. Overall, scATAC-seq read counts were positively correlated
with CREs’ baseline activities at these low-variability CREs, and the SCATE-fitted
normalization functions were able to capture the systematic relationship (i.e., technical
biases) between the scATAC-seq and bulk DNase-seq data.
Figure 3-6 shows the number of CRE clusters adaptively chosen by SCATE. For
each cell type, there are four plots corresponding to SCATE analyses by pooling
different number of cells, with the cell number n shown on top of each plot. For each
n, n cells were randomly sampled from the scATAC-seq dataset and pooled. SCATE
was applied to the pooled data to automatically choose the CRE cluster number. This
procedure was repeated ten times. The histogram shows the empirical distribution of
the cluster number chosen by SCATE in these ten independent cell samplings without
using any information from the gold standard bulk DNase-seq. As a benchmark, we
also ran SCATE by manually setting the CRE cluster number K to different values.
For each K, we computed the Pearson correlation between the SCATE-estimated CRE
activities in scATAC-seq and the gold standard CRE activities in bulk DNase-seq. The
dots in each plot show the correlation coefficients for different Ks, also averaged across
the ten independent cell samplings. The dot with the largest correlation coefficient
corresponds to the true optimal cluster number. In real applications this true optimal
cluster number would be unknown because one would not have the bulk DNase-seq as
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Figure 3-5. Normalization of scATAC-seq and bulk DNase-seq data. The scATAC-seq
read counts versus baseline mean activities are shown for low-variability CREs in GM12878
(top panel) and K562 (bottom panel). Each blue dot is a low-variability CRE, defined as
a CRE with almost constant activity across diverse cell types in BDDB bulk DNase-seq
samples. Different plots correspond to analyses based on pooling different number of cells.
In each plot, the red curve is the technical bias function fitted by SCATE.
the gold standard to help with choosing K.
Figure 3-6 shows that the CRE cluster number automatically chosen by SCATE
(histogram) typically was close to the true optimal cluster number (the dot with the
highest correlation). For instance, for analyzing a single GM12878 cell, the cluster
number chosen by SCATE had its mode at 1250, and the true optimal cluster number
was 2500. For analyzing 220 GM12878 cells, the cluster number chosen by SCATE
had its mode at 521820, and the true optimal cluster number was also 521820.
Figure 3-6 also shows that, as the cell number increases, both the true optimal CRE
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Figure 3-6. Adaptive tuning of analysis resolution. The number of CRE clusters
automatically chosen by SCATE via cross-validation (histogram) is compared with the true
optimal CRE cluster number determined by external information from the gold standard
bulk DNase-seq data (dots). Different plots correspond to different cell types and pooled
cell number. In each plot, the histogram shows the CRE cluster number chosen by SCATE
in 10 independent cell samplings. The dots show the true correlation between the gold
standard bulk DNase-seq signal and the SCATE-reconstructed scATAC-seq signal (both at
log-scale) at each CRE cluster number, averaged across the 10 cell samplings. The dot
with the highest correlation is the true optimal cluster number.
cluster number implies decreasing cluster size. Thus, SCATE adaptively changes
analysis resolution: as more data are available for each CRE, SCATE gradually
decreases the number of CREs in each cluster for information sharing. This allows
SCATE to maximally retain CRE-specific information.
Figure 3-7 compares SCATE-reconstructed scATAC-seq signal with bulk DNase-seq
signal in GM12878 and K562 in an example genomic region. The figure has six columns
corresponding to different cell types and different pooled cell numbers. For benchmark
purpose, the figure also compares SCATE with a number of other methods, all run
based on 200bp non-overlapping genomic windows. Here “Raw reads” displays the
scATAC-seq read count pooled across cells for each genomic window. This approach
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is used by Dr.seq2. Raw read counts are also used by scABC to characterize CRE
activities in single cells, but scABC does not pool cells. “Binary” converts read counts
in each cell to a binary accessibility vector and then adds up the binary accessibility
vectors across cells. This approach is used by Cicero. Binary accessibility is also used
by Scasat, Destin, PRISM and cisTopic as their data matrix. ChromVAR, SCRAT
and BROCKMAN only analyze and report aggregated CRE pathway activities rather
than activities of individual CREs. Thus, they cannot be compared here. However, for
our previously developed SCRAT, we were able to modify the codes to estimate CRE
activities by directly using pathway activities. This results in three methods, “SCRAT
500 CRE cluster”, “SCRAT 1000 CRE cluster” and “SCRAT 2000 CRE cluster”
shown in the figure. Here, CREs were clustered into 500, 1000 or 2000 clusters as in
SCRAT using the bulk DNase-seq data in BDDB. For each CRE cluster, the average
normalized scATAC-seq read count across all CREs in the cluster was calculated. It
was then assigned back to each CRE in the cluster to represent the estimated CRE
activity. The “Raw reads” method can be viewed as a special case of the “SCRAT
CRE cluster” method when the cluster number is equal to the CRE number (i.e., each
CRE is a cluster). “Average DNase-seq” shows the average normalized read count
profile of bulk DNase-seq samples in BDDB. It reflects CRE’s baseline mean activity.
Figure 3-7 shows that SCATE-reconstructed scATAC-seq signals accurately cap-
tured the variation of CRE activities in bulk DNase-seq across different genomic loci
and different cell types, whereas CRE activities estimated using raw read counts,
binarized chromatin accessibility, or SCRAT CRE cluster methods all failed to accu-
rately capture the bulk DNase-seq landscape. Interestingly, SCATE was able to use
scATAC-seq data from one single cell to accurately estimate CRE activities in bulk
DNase-seq. By contrast, the raw read count and binary accessibility methods both
failed due to data sparsity (e.g., see regions in blue boxes). The SCRAT CRE cluster



























Figure 3-7. Comparison of different methods in an example genomic region. Each row is
a method, each column corresponds to a different cell type or pooled cell number. All
columns show the same genomic region. The blue boxes highlight two CREs. The left
CRE occurs in both GM12878 and K562. It cannot be detected by Raw reads, Binary and
SCRAT CRE cluster methods in a single cell, but can be detected by Average DNase-seq
and SCATE. The right CRE is K562-specific. It cannot be detected by Average DNase-seq
but can be detected by SCATE.
CRE cluster and ignores CRE-specific behaviors, and (2) it does not adaptively tune
the analysis resolution as in SCATE to maximally retain CRE-specific signals. The
“Average DNase-seq” approach produced relatively continuous signals and captured
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some variation across genomic loci in the GM12878 and K562 bulk DNase-seq data.
However, it was unable to capture cell-type-specific signals, such as those shown in
the blue boxes.
3.3.5 Analysis of a homogeneous cell population - a system-
atic evaluation
Next, we systematically evaluated SCATE and the other methods in all three bench-
mark datasets by treating the six test cell types as six homogeneous cell populations.
The evaluation was based on the correlation with gold standard bulk regulome data,
peak calling performance using reconstructed signals, and ability to predict transcrip-
tion factor binding sites (TFBSs). Note that even though each test cell type could
potentially be decomposed further into multiple cell subtypes, we could not conduct
the analysis at the cell subtype level because the gold standard bulk regulome data for
those cell subtypes are unavailable and the subtype label of each cell is unknown. Thus,
for benchmark purpose, here we defined “homogeneous” at a coarser scale and view
cells from each test cell type as homogeneous. This is reasonable because according to
statistical theory, cells in the same cell population (regardless of the composition of the
population) are exchangeable in the sense that, without knowing the finer structure of
the population, the expectation of the behavior of any cell randomly drawn from the
population is equal to the population’s bulk (mean) behavior.
In the first evaluation, we computed the Pearson correlation between the scATAC-
seq signals reconstructed by each method and the gold standard bulk signals across
all CREs. As one example, Figure 3-8A shows the results based on pooling scATAC-
seq data from 10 GM12878 cells. Among all methods, SCATE showed the highest
correlation with the bulk gold standard. We performed the same analysis on all six
test cell types by pooling different cell numbers. For each cell number, we repeated
the analysis ten times using ten independent cell samplings. The median performance
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of the ten analyses was then compared. Figure 3-8B shows that SCATE consistently
outperformed all the other methods and showed the strongest correlation with the
bulk gold standards in all test data. When the pooled cell number was small, the
improvement of SCATE over many methods was substantial. For instance, for the
analysis of one single Monocyte cell, the correlation was 0.22, 0.22, 0.57, 0.57 and 0.57
for Raw reads, Binary, SCRAT 500, 1000 and 2000 CRE cluster methods, respectively.
For SCATE, it was 0.67, representing an improvement of 18%∼205% over the other
methods. Of note, the Average DNase-seq method performed relatively well in this
evaluation when the cell number was small. However, as we will show later, the
average DNase-seq profile cannot predict changes in CRE activity between different
cell types, but SCATE can.
In the second evaluation, we performed peak calling using scATAC-seq signals
reconstucted by SCATE and other methods. Peak calling is a common task in
DNase-seq or ATAC-seq data analyses. Its objective is to find genomic regions with
significantly enriched signals. We implemented a peak calling algorithm using a
moving average approach (see Methods) and applied it to signals reconstructed by
each method (SCATE, Raw reads, Binary, SCRAT CRE cluster, and Average DNase-
seq). In addition, we also performed peak calling by applying MACS2 [82] to the
pseudobulk sample obtained by pooling cells. The peak calling performance of each
method was evaluated using the sensitivity versus false discovery rate (FDR) curve,
where the “truth” was defined by the peaks called from the bulk gold standard data.
Here sensitivity is the proportion of true bulk peaks discovered by scATAC-seq, and
FDR is the proportion of scATAC-seq peaks that are false (i.e., not found in bulk
peaks). As one example, Figure 3-9A compares the sensitivity-FDR curves of different
methods when they were applied to the pooled scATAC-seq data from 25 GM12878
cells. For each curve, we computed the area under the curve (AUC). Figure 3-9B
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Figure 3-8. Correlation between reconstructed and true CRE activities. (A): Scatterplots
showing true bulk CRE activities vs. CRE activities estimated by different methods in an
analysis that pools 10 GM12878 cells. In this analysis, both activities are at log-scale.
(B): The correlation between the scATAC-seq reconstructed and true bulk regulome for
different methods. Each plot corresponds to a test cell type. In each plot, the correlation
is shown as a function of the pooled cell number.
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plot, the analyses were run by pooling different numbers of cells, and the median
AUC from 10 independent cell samplings was plotted as a function of the cell number.
Once again, SCATE showed the best overall peak calling performance. When the cell
number was small, the improvement was substantial. For analyzing one Monocyte cell,
for example, the AUC of SCATE was 0.4, whereas the AUCs for the other methods
(except for Average DNase-seq) were all below 0.21. Thus, SCATE improved over
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Figure 3-9. Peak calling performance. (A): The sensitivity versus FDR curve is shown
for different peak calling methods in an analysis that pools 25 GM12878 cells. (B): The
area under the sensitivity-FDR curve (AUC) is shown as a function of pooled cell number
for different methods. Each plot corresponds to a different test cell type.
In the third evaluation, we used signals reconstructed by each method to predict
TFBSs. We evaluated 28 TFs in GM12878 and 29 TFs in K562. As gold standard, we
collected ChIP-seq peaks for these TFs from the ENCODE [80]. For the other cell
types, we did not find TF ChIP-seq data suitable for evaluation. Therefore, our TFBS
prediciton analysis was focused on GM12878 and K562. To predict TFBSs of a TF,
we mapped its motif sites in the genome using CisGenome [91]. Genomic windows
overlapping with motif sites were sorted based on their reconstructed scATAC-seq
signals. Windows with the highest signals were labeled as predicted TFBSs (Figure 3-
10A). Motif-containing windows that overlap with TF ChIP-seq peaks were viewed as
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gold standard true TFBSs. Based on this, we generated the sensitivity-FDR curve for
each TF by gradually relaxing the TFBS calling cutoff. As one example, Figure 3-10B
shows the sensitivity-FDR curves of different methods for predicting ELF1 binding
sites by pooling scATAC-seq data from 25 GM12878 cells. For each TF and cell type,
we performed this analysis using different cell numbers. For each cell number, the
median area under the sensitivity-FDR curve (AUC) of 10 independent cell samplings
was computed. As two examples, Figure 3-10C shows the AUCs for different methods
as a function of pooled cell number for two TFs: ELF1 in GM12878 and JUND in
K562. Finally, Figure 3-10D shows the average performance of all 28 TFs in GM12878
and 29 TFs in K562. In all these analyses, SCATE robustly outperformed all the other
methods. The overall improvement was substantial (e.g., see K562 in Figure 3-10D).
3.3.6 Analysis of a heterogeneous cell population - demon-
stration and systematic evaluation
To demonstrate the analysis of a heterogeneous cell population, we mixed GM12878
and K562 cells from Dataset 1 with different ratios to create synthetic samples with
different heterogeneity levels. Each synthetic sample had 100 cells representing a
mixture of GM12878 and K562 cells. The percentage of GM12878 cells was set to x =
10%, 30% and 50%, respectively. For each percentage x, ten synthetic samples were
created using independently sampled cells. The median performance of each method
on the ten analyses was compared.
Each synthetic sample was analyzed by first clustering cells using the default
cell clustering algorithm in SCATE. SCATE and other methods were then used to
estimate CRE activities for each cell cluster. The number of cell clusters automatically
determined by SCATE in these samples ranged from 2-5 (Figure 3-11A). Figure 3-11B
shows one example in which cells were grouped into 2 clusters.
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Figure 3-10. TFBS prediction performance. (A): An illustration of TFBS prediction in
an example genomic region. The region contains a genomic bin with ELF1 motif and
high SCATE-reconstructed CRE activity in GM12878. The bin is predicted as a ELF1
binding site. The prediction can be validated by ELF1 ChIP-seq peak in GM12878. (B):
An example sensitivity versus FDR curve for comparing different methods for predicting
ELF1 TFBSs in an analysis that pools 25 GM12878 cells. (C): Two examples (ELF1 in
GM12878 and JUND in K562) that illustrate the method comparison across different cell
numbers. In each example, analyses are performed by pooling different numbers of cells.
The median AUC under the sensitivity-FDR curve from 10 independent cell samplings is
shown as a function of pooled cell number. (D): The averaged AUC across all TFs is
shown as a function of pooled cell number in GM12878 and K562 respectively.
annotated each cell cluster based on its dominant cell type. A cell cluster was labeled
as “predicted GM12878” if over 70% of cells in the cluster were indeed GM12878 cells.
Similarly, a cell cluster with ≥70% K562 cells was labeled as “predicted K562”. All
other clusters were labeled as “ambiguous”. For a given sample, if at least one cell
cluster was labeled as “predicted cell type X” (X = GM12878 or K562), we say that
cell type X was detected. Based on this definition, both GM12878 and K562 can be
detected in all samples (Figure 3-11C). Note that one cell type may be identified by
multiple cell clusters. Given the cell type annotation, we then compared the regulome
of each cell type reconstructed by SCATE and other methods. Since all methods used
87
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Figure 3-11. Analyses of a heterogeneous cell population. (A): Distribution of cell cluster
numbers obtained by SCATE for synthetic samples with different cell mixing proportions.
GM12878 and K562 cells are mixed at different proportions. For each mixing proportion, 10
synthetic samples are created and analyzed. (B): An example tSNE plot showing clustering
of cells in a synthetic sample. (C): At each cell mixing proportion, the frequency that each
cell type is detected in the 10 synthetic samples is shown. (D)-(F): The correlation between
the scATAC-seq reconstructed and true bulk regulome in (D) GM12878, (E) K562, and (F)
GM12878 and K562 combined for different methods is shown as a function of cell mixing
proportion (GM12878 cell percentage). (G): The peak calling AUC (GM12878 and K562
combined) vs. cell mixing proportion. (H): The TFBS prediction AUC (GM12878 and
K562 combined) vs. cell mixing proportion. (I): The correlation between the scATAC-seq
reconstructed and true bulk differential log-CRE activities is shown as a function of cell
mixing proportion. (J)-(L): Similar analyses in samples consisting of human CMP and
monocyte cells, including (J) correlation between reconstructed and true bulk log-CRE
activities, (K) peak calling AUC, and (L) correlation between predicted and true differential
log-CRE activities. (M)-(O): Similar analyses in samples consisting of mouse thymus
and brain cells, including (M) correlation between reconstructed and true bulk log-CRE
activities, (K) peak calling AUC, and (L) correlation between predicted and true differential
log-CRE activities.
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the same cell clustering results, the comparison of their signal reconstruction ability is
a fair comparison. We conducted four types of comparisons.
First, we asked whether the regulome reconstructed by each method for each
predicted cell type can accurately recover the cell type’s true regulome measured by
the gold standard bulk data. Take GM12878 as an example. For each cell cluster
predicted as GM12878, the Pearson correlation between the cluster’s reconstructed
scATAC-seq signal and the gold standard bulk GM12878 DNase-seq data was computed.
If a sample had two or more cell clusters predicted as GM12878, each cluster was
analyzed separately. The median correlation of all such clusters in ten independent
synthetic samples is shown in Figure 3-11D. SCATE again performed the best. When
the proportion of GM12878 cells in a sample was small, the improvement by SCATE
was larger. Figure 3-11E shows the same analysis for K562, but the performance was
shown as a function of GM12878 cell proportion. Figure 3-11F shows the combined
results. Here at each cell mixing proportion, the median scATAC-bulk correlation of
all cell clusters predicted either as GM12878 or K562 was shown. In all these analyses,
SCATE consistently performed the best.
Second, we conducted peak calling and evaluated each method’s ability to recover
true peaks in each cell type. Here the truth was defined as peaks called from the
gold standard bulk data, and the evaluation was conducted similar to Figure 3-9.
Figure 3-11G shows the median AUC of all cell clusters predicted either as GM12878
or K562 as a function of cell mixing proportion. SCATE robustly outperformed the
other methods.
Third, we compared different methods in terms of their ability to predict TFBSs.
TFBS prediction and evaluation were performed similar to Figure 3-10. The results
are shown in Figure 3-11H, in which the median AUC for each method is plotted as a
function of cell mixing proportion. SCATE produced the best prediction accuracy.
Last but not least, we applied different methods to predict differential CRE
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activities between different cell types, which is crucial for characterizing the regulatory
landscape of a heterogeneous sample. Here we collected all pairs of cell clusters that
were predicted as two different cell types (i.e., one cluster was “predicted GM12878”
and the other cluster was “predicted K562”; ambiguous cell clusters were excluded).
For each such pair, we computed the difference of reconstructed CRE activities
between the two cell clusters. We then compared this predicted difference with the
true differential CRE activities derived from the gold standard bulk DNase-seq data
for GM12878 and K562. The Pearson correlation between the predicted and true
differential signals was calculated. As one example, Figure 3-12 shows the results for
a cell cluster pair in a synthetic sample in which 30% of cells was GM12878. SCATE
best recovered the differential CRE activities (Correlation = 0.43). Figure 3-11I shows
the median correlation across ten independent synthetic samples at each cell mixing
proportion. Once again, SCATE performed the best.
Figure 3-12. An example of predicting differential CRE activities. Scatterplots showing
true bulk differential log-CRE activities vs. differential log-CRE activities estimated by
different methods in an analysis of a synthetic sample consisting of 30 GM12878 and 70
K562 cells.
We note that the Average DNase-seq method completely failed for predicting
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differential signals between two cell types (Correlation = 0) (Figs. 9I,10), even though
it performed relatively well for estimating CRE activities within one cell type, and
peak calling and TFBS prediction in one cell type (Figs. 6,7,8,9F-H). Similarly, each
of the other methods may perform well in some datasets or analyses but not in others.
SCATE is the only method that robustly performed the best in all our analyses.
Similar to GM12878 and K562 (Dataset 1), we also constructed heterogeneous
cell populations using the other two datasets (Datasets 2 and 3) and used them to
evaluate different methods. The results are shown in Figure 3-11J-O and Figure 3-13.
For these two datasets, we did not perform TFBS prediction due to lack of gold
standard ChIP-seq data. For estimating CRE activities (Figure 3-11J,M), peak calling
(Figure 3-11K,N) and predicting differential CRE activities (Figure 3-11L,O), SCATE
again outperformed all the other methods. In many cases, the improvement was
substantial (e.g., Figure 3-11K,L,N,O).
3.3.7 Analysis of scATAC-seq data from human hematopoi-
etic differentiation
To further demonstrate and evaluate SCATE, we analyzed a scATAC-seq dataset
generated by [83] which consists of 1920 cells from 8 human hematopoietic cell types
for which corresponding bulk ATAC-seq data are available. These cell types include
hematopoietic stem cell (HSC), multipotent progenitor (MPP), lymphoid-primed
multipotent progenitor (LMPP), common myeloid progenitor (CMP), common lym-
phoid progenitor (CLP), granulocyte-macrophage progenitor (GMP), megakaryocyte-
erythrocyte progenitor (MEP) and monocyte (Mono). In this dataset, the true
cell type label of each cell was known since cells were obtained by cell sorting.
Figure 3-14A shows the tSNE [92] plot of all cells color-coded by their true cell
types. In the plot, different cell types were distributed along three major differenti-

























































































Dataset 2 (CMP, Monocyte)
Dataset 3 (Thymus, Brain)
Figure 3-13. Analyses of a heterogeneous cell population created using (A) Dataset 2
and (B) Dataset 3. In each dataset, the left plot shows distribution of cell cluster numbers
obtained by SCATE for synthetic samples with different cell mixing proportions. For each
mixing proportion, 10 synthetic samples were created and analyzed. The right plot shows
the frequency that each cell type is detected in the 10 synthetic samples at each cell
mixing proportion.
HSC→MPP→CMP→MEP; lymphoid: HSC→MPP→LMPP→CLP), which are con-
sistent with known biology. For method evaluation, we analyzed all cells together as a
heterogeneous cell population and pretended that the cell type labels were unknown.
We also downloaded and processed bulk ATAC-seq data for these 8 cell types from
92
[90] and used them as the gold standard to assess regulome reconstruction accuracy.
Using its default cell clustering method, SCATE identified 14 cell clusters. To
evaluate the performance of this unsupervised analysis for recovering true biology, we
first assigned a cell type label for each cluster. A cluster was annotated as “predicted
cell type X” if the cluster contained at least two cells and the true cell type label of
≥70% cells from the cluster was cell type X. Clusters that cannot be annotated using
this criterion were labeled as ambiguous. In this way, we were able to unambiguously
annotate 9 clusters. Since multiple clusters may be annotated with the same cell type,
these 9 annotated clusters corresponded to a total of 6 cell types (Figure 3-14B). For
these 9 clusters, one can evaluate signal reconstruction accuracy because the bulk
ATAC-seq data for the annotated cell type was available. Each cluster was treated
as a homogeneous cell population by SCATE and other methods in our analysis (as
one would do in real applications), even though the cluster actually may not be pure
and may contain cells from more than one cell types. Figure 3-14D compares the
Pearson correlation between the gold standard bulk signal and the CRE activities
reconstructed from scATAC-seq by different methods. Each boxplot contains 9 data
points corresponding to the 9 cell clusters. Figure 3-14E compares the peak calling
performance (AUC under the sensitivity-FDR curve). Figure 3-14F compares the
accuracy for predicting differential CRE activities between different cell types. Here
each data point in the boxplot is a pair of cell clusters annotated with two different
cell types. The Pearson correlation between the gold standard bulk differential signal
and differential signal reconstructed from scATAC-seq was computed and compared.
In all these analyses, SCATE outperformed the other methods. Figure 3-14J shows an
example genomic region in a HSC cell cluster. SCATE most accurately reconstructed
the bulk ATAC-seq signal in HSC.
SCATE provides users with the flexibility to specify their own cell cluster number
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Figure 3-14. Analysis of human hematopoietic differentiation cell types. (A): tSNE
plot showing cells color-coded by their true cell types. (B): tSNE plot showing cells
color-coded by their predicted cell types. Using the default setting, SCATE grouped cells
into 14 clusters (numbers in the plot indicate cluster centers). The clusters that can be
unambiguously linked to a cell type are color-coded by cell type. (C): Similar to (B), but
cells are clustered using user-specified cluster number (38 clusters). (D)-(F): Regulome
reconstruction performance of different methods in the default analysis, including (D)
correlation between reconstructed and true bulk log-CRE activities, (E) peak calling AUC,
and (F) correlation between predicted and true differential log-CRE activities. (G)-(I):
Regulome reconstruction performance using user-specified cluster number (38 clusters),
including (G) correlation between reconstructed and true bulk log-CRE activities, (H) peak
calling AUC, and (I) correlation between predicted and true differential log-CRE activities.
(J): Comparison of different methods in an example genomic region in HSC cell cluster in
the default analysis.
user-provided cell cluster number or clustering structure. For instance, suppose one
is not satisfied with the default cell clustering and wants to increase the granularity
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of clustering to make each cluster smaller and more homogeneous, one can manually
adjust the cluster number. To demonstrate, we increased the cluster number to 38
so that each cluster had approximately 50 cells on average. After rerunning SCATE,
24 of the 38 cell clusters can be unambiguously annotated, identifying a total of 7
cell types (Figure 3-14C). As a comparison, the default analysis only unambiguously
identified 6 cell types. For the unambiguously annotated cell clusters, Figure 3-14G-I
compares the performance of different methods for reconstructing CRE activities,
peak calling, and estimating differential CRE activities between different cell types.
SCATE still delivered the best performance. Since the average cell cluster size became
smaller, the performance of some methods decreased substantially in some analyses
(e.g., the CRE reconstruction and peak calling accuracy for Raw reads and Binary in
Figure 3-14G,H). In these cases, the benefit from SCATE was even more obvious.
3.4 Discussion
In summary, SCATE provides a new tool for analyzing scATAC-seq data. Our analyses
show that it robustly outperforms the existing methods for reconstructing activities of
each individual CRE. In many cases, the gain can be substantial.
The main novelty of SCATE is its unique strategy to reconstruct CRE activities
from sparse data by (1) integrating data from both similar CREs and cells, (2)
leveraging the rich information provided by publicly available regulome data, and
(3) adaptively optimizing the analysis resolution based on available data. Coupled
with appropriate cell clustering, SCATE allows one to systematically characterize the
regulatory landscape of a heterogeneous sample via unsupervised identification of cell
subpopulations and reconstruction of their chromatin accessibility profile at the single
CRE resolution.
Since many methods for clustering cells using scATAC-seq data have been developed
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(Table 3-I), cell clustering per se is not the focus of this article. In principle, the SCATE
model may be coupled with any cell clustering method. While our implementation
uses model-based clustering as the default, users are provided with the option to use
their own cell clustering results as the input for SCATE.
The basic framework adopted by SCATE to improve the analysis of sparse data by
integrating multiple sources of information is general. In principle, a similar approach
may also be used to analyze other types of single-cell epigenomic data such as single-cell
DNase-seq or ChIP-seq, and possibly single-cell Hi-C [93].
Our current implementation of SCATE is focused on identifying and characterizing
cell subpopulations. A future direction is to extend this framework to other types of
analyses such as pseudotime analysis [39] to allow the study of CRE activities along
continuous pseudotemporal trajectories. Another future direction is to develop new




RAISIN: Regression Analysis in
Single-cell RNA-Seq with multiple
samples
4.1 Introduction
Transcriptome profiling by single-cell RNA-sequencing (scRNA-seq) [20, 45] is rapidly
transforming biomedical research. The ability of scRNA-seq to analyze individual
cells enables systematic discovery and characterization of known and unknown cell
populations in a biological sample. Identifying differentially expressed genes associated
with various biological or technical factors such as cell type or experimental condition
is one of the most common tasks for analyzing scRNA-seq data [94, 95]. While many
early studies only analyze cells from one sample, recent studies increasingly analyze
multiple samples such as multiple biological replicates in order to make discoveries
generalizable to the population [28, 96]. For analyzing data with multiple samples, it
is important to consider both cell-to-cell variation and sample-to-sample variation in
order to distinguish true biological signals from noises. However, the most commonly
used differential expression (DE) analysis methods either ignore sample-level variation
[42] or do not consider cell-level variation [97]. Applying them to multi-sample data
will produce unsatisfactory or misleading results.
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To solve this problem, we developed RAISIN to support Regression Analysis In
SINgle-cell RNA-seq datasets with multiple samples. RAISIN takes raw gene expression
counts and experimental design as input and provides a complete preprocessing pipeline
consisting of cell and gene filtering, normalization and gene expression imputation.
It then aligns cells of the same type across samples and identify cell subpopulations
through clustering. DE analysis is then performed using a flexible mixed effects
regression framework that accounts for both sample-level and cell-level variances
(Figure 4-1A). The classical linear mixed effects model (LMM) [98] does not consider
small sample size or small cell number in rare cell populations, which are common in
scRNA-seq studies and can lead to poor variance estimation and reduced statistical
power. Fitting mixed effects models to large datasets consisting of many samples and
millions of cells is also computationally challenging. To address these issues, RAISIN
combines the mixed model with a hierarchical model to regularize variances, and a
new model fitting algorithm is developed to efficiently handle large datasets.
4.2 Methods
4.2.1 RAISIN overview
Given scRNA-seq data from multiple samples, a basic RAISIN analysis consists of data
preprocessing and differential expression detection. The data preprocessing includes
cell and gene filtering, normalization, imputation, aligning cells across samples, and
clustering cells to identify cell subpopulations. The differential expression detection
analyzes each cell subpopulation or compares different cell subpopulations to identify
gene expression associated with user-specified biological or experimental variables
(e.g., normal vs. disease, age, sex, etc.).
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4.2.2 RAISIN data preprocessing
The data preprocessing of RAISIN is a multi-step procedure. It is implemented in a
modular fashion so that users can conveniently replace each step by their own functions
or new methods. The default preprocessing pipeline is described below. Users have
options to change the parameter values.
Cell and gene filtering. By default, cells with less than 5,000 reads are removed.
We also remove cells with more than 50,000 reads because an extremely large total read
count may indicate a doublet rather than a single cell. Since high mitochondrial gene
expression is often associated with low sample quality, cells in which mitochondrial
gene reads account for more than 10% of all reads are also filtered out. For gene
filtering, we retain genes that have non-zero read count in at least 1% of cells in at
least one sample and remove the other genes.
Normalization. The raw read counts are normalized across cells using the cell size
factors estimated by SCRAN [99] (using R scran package) which is run across all cells
and samples.
Imputation. SAVER [100] is run on SCRAN normalized data in each sample to
impute dropouts and quantify gene expression values. The output of this step is log2-
transformed gene expression. A pseudocount of 1 is added before log-transformation
to avoid log-zero.
Aligning cells across samples. In order to track cells of the same cell type across
samples, the Mutual Nearest Neighbors (MNN) [101] approach is used to align cells
from different samples. To this end, we first identify genes with (1) expression≥0.1
in at least 1% of all cells across all samples, and (2) positive biological variation
(higher variation than expected controlling for mean expression) as determined by the
decomposeVar function in scran package. The fastMNN function in scran package
is then run using these genes and default settings. This function maps all cells to a
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common principal component (PC) space and corrects cells’ positions in this space to
removes systematic differences among samples. In this way, cells of the same type but
from different samples are aligned together. By default, MNN generates 50 PCs. A
subset of 50 PCs are further chosen for follow-up analysis. The optimal number of
dimensions to use is chosen using an elbow method same as in TSCAN [43]. Cells’
MNN-corrected coordinates in top L PCs are retained. The optimal L is determined
using the piece-wise linear elbow method described in TSCAN [43] and is truncated
at 50 (i.e., L ≤ 50).
Clustering cells to identify cell subpopulations. Using the MNN-corrected coordi-
nates in the top L PCs, cells are clustered using K-means clustering. Users can either
specify the cluster number by themselves or let RAISIN to automatically choose the
cluster number. To choose the cluster number automatically, K-means clustering is
first run using an relatively large initial cluster number K0 (the default K0 = 100).
The K0 initial clusters are then clustered further using hierarchical clustering and
merged along the dendrogram to obtain k = K0 − 1, K0 − 2, ..., 2 clusters. For each
cluster number k, we calculate the ratio between the within-cluster sum of squared
residuals (RSS) and total data variance (= within-cluster RSS + between-cluster RSS).
This ratio, denoted as rk, characterizes the proportion data variance that cannot be
explained by clustering. It decreases with increasing cluster number k. We calculate
the difference rk−1 − rk for k = 2, 3, ..., K0. These differences are log10 transformed
and grouped into histogram bins. Denote the lower bound of the bin with the largest
number of elements as c. The smallest k that satisfies rk−1 − rk ≤ 10c is chosen as the
cluster number.
Visualization. To visualize cell clustering, UMAP (umap package in R) is applied
to cells’ MNN-corrected coordinates in the top L PCs. UMAP is run with its default
settings which reduce cells’ dimension from L to 2.
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4.2.3 RAISIN differential expression (DE) analysis
RAISIN uses a mixed effects regression model with variance shrinkage to detect
differential expression. In order to introduce the method, first consider a simple
scenario of comparing two sample types (e.g., cancer vs. normal). For such a
comparison, RAISIN will analyze each cell subpopulation separately. For a given cell
subpopulation, let ygsc be the gene expression value of gene g in sample s and cell c,
and let yg be the column vector consisting of ygscs from all samples and cells in the
cell subpopulation. Here ygscs are normalized gene expression values after imputation
but without MNN correction because biological differences between different sample
types (e.g., normal vs. disease) would be removed from the MNN-corrected expression
values. Thus, MNN is only used to align samples to identify cells of the same type
across samples.
A conventional linear mixed model (LMM) assumes that
yg = Xβg + Zug + eg (4.1)
Here Xβg models fixed effects, Zug models the sample-level random effects, and eg
models the cell-level random effects. The matrices X and Z are known experiment
design information. βg contains unknown regression coefficients of interest. The
random effects ug and eg are unobserved random vectors with zero mean. Their
variances var(ug) = Σg and var(eg) = Ωg characterize cross-sample variability and
cross-cell variability, respectively. Both Σg and Ωg are unknown. In this study, they
are assumed to be diagonal matrices with block structures such that diagonal elements
within the same block are equal but those from different blocks can have different
values. For Ωg, cells from the same sample are treated as a block. For Σg, the block
structure is given by users. For example, if samples are from multiple groups (e.g.,
normal vs. disease), one can treat each group as a block. Under this framework,
differential expression is detected by evaluating linear combinations of regression
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coefficients βg.
Let xTsc and zTsc denote the row corresponding to sample s and cell c in X and Z
respectively. The model can also be written as
ygsc = xTscβg + zTscug + egsc (4.2)
For instance, suppose one compares two normal control samples (s = 1, 2) with
two tumor samples (s = 3, 4), and each sample has two cells (c = 1, 2) in the cell
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ygsc = βg0 + xscβg1 + ugs + egsc (4.4)
where the dummy variable xsc indicates whether a cell comes from a normal sample
(xsc = 0) or a tumor sample (xsc = 1). ugs and egsc are independent sample-level and
cell-level random effects respectively. Finding differential expression between tumor
and normal amounts to evaluating whether βg1 is equal to zero or not.
In this example, one can assume var(ug1) = var(ug2) = σ2g1 and var(ug3) =
var(ug4) = σ2g2 (i.e., samples of the same type have the same variance), which implies
















. In other words, Σg is a
diagonal matrix with two blocks. Here ⊗ denotes Kronecker product and I denotes
an identity matrix. Similarly, one can assume var(egsc) = ω2gs (i.e., cells in the same
sample have the same variance conditional on their sample-level mean xTscβg + zTscug)










⊗ I2×2 is a diagonal matrix with four blocks.
102
In the LMM, the marginal variance of yg is ZΣgZT + Ωg, which is no longer a
diagonal matrix. Thus, the model can deal with correlation among cells from the
same sample. By contrast, the Wilcoxon test used by Seurat, MAST, scDD, and t
test used in our benchmark analysis do not consider sample-level variation. This is
similar to removing the Zu component from the LMM model and treating all cells as
independent samples for testing differential expression. Since the actual number of
independent samples (i.e. effective sample size) is much smaller than the cell number,
these methods will underestimate the uncertainty of βg estimates and report overly
optimistic p-values and false discovery rates (i.e., the actual error rates can be much
higher than the reported error rates). By considering correlation among cells, LMM
improves the characterization of the uncertainty of βg estimates and hence can better
control the false discovery rates.
The conventional LMM has several limitations. First, it treats Σg and Ωg as fixed
unknown parameters. When the number of samples or the number of cells in a cell
subpopulation is small, the estimates of Σg and Ωg have high variability and hence
are highly unstable, leading to reduced statistical power. Second, fitting LMM often
requires iterative algorithms since closed-form solutions are unavailable except for a
few special cases. When the cell number or sample size is large, fitting the model
for tens of thousands of genes using the conventional algorithms is computationally
intensive. For cell atlases with millions of cells, model fitting can be very slow.
To overcome these limitations, RAISIN extends LMM using an empirical Bayes
framework which introduces a number of new components.
First, we reformulate the LMM using cells’ average gene expression in each cell
subpopulation and sample. For the given cell subpopulation, let ns be the cell number
of the subpopulation in sample s, and ˜︁ygs = ∑︁c ygsc/ns be the average expression of
cells in the subpopulation in sample s. Let S be the total number of samples. The
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LMM is rewritten as
˜︁yg = ˜︂Xβg + ˜︁Zug + ˜︁eg (4.5)
or
˜︁ygs = ˜︁xTs βg + ˜︁zTs ug + ˜︁egs (4.6)
























˜︁ygs = βg0 + ˜︁xsβg1 + ugs + ˜︁egs (4.8)










and var(˜︁eg) = ˜︁Ωg = diag {︃ω2g1n1 , . . . , ω2g4n4
}︃
.
This model reformulation can substantially reduce the dimension of y from ∑︁Ss=1 ns
(which can be millions of cells) to S (e.g., a few dozens of samples) and hence simplify
the computation.
Second, in order to deal with unstable variance estimates in small cell number
scenarios (e.g., in a rare cell subpopulation), we assume that parameters in ˜︁Ωg
from different genes are random variables and their prior distributions are shared
across genes. This allows one to derive shrinkage estimators to improve variance
estimation by borrowing information across genes. Specifically, let s denote samples
and
{︂
ω2gs : s = 1, . . . , S
}︂
be the set of unique variance parameters in ˜︁Ωg. We assume
˜︁egs ∼ N(0, ω2gs
ns
) (4.9)
ω2gs ∼ IG(θs, ϕs) (4.10)
where N(., .) represents normal distribution, and IG(., .) represents inverse-gamma
distribution whose parameters θs and ϕs are shared by all genes. We estimate θs and
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ϕs using data from all genes via moment estimators similar to limma. An empirical
Bayes shrinkage estimator is then used to estimate ω2gs for each individual gene by its
posterior mean.
Third, in order to deal with unstable variance estimates in small sample size scenar-
ios, we assume that parameters in Σg are random variables whose prior distributions
do not depend on specific genes. Assume Σg has L blocks and use l to index the block.
Let
{︂
σ2gl : l = 1, . . . , L
}︂
be the set of unique variance parameters in Σg. For a sample
s that belongs to variance block l, we assume
ugs ∼ N(0, σ2gl) (4.11)
σ2gl ∼ Gamma(αl, γl) (4.12)
The parameters αl and γl in the prior distribution are gene-independent and are
estimated using all genes via moment estimation. σ2gl is then estimated using its
posterior mean. Due to multi-level variance modeling, the posterior mean of σ2gl does
not have a closed-form. Thus, Gauss-Laguerre quadrature is used to obtain a numerical
approximation. In theory, one could also use inverse-gamma distribution as the prior
for σ2gl. However, computing Gauss-Laguerre quadrature under the inverse-gamma
assumption empirically is unstable numerically. Thus, gamma distribution is used
instead since it makes the computation numerically stable.
Fourth, suppose the goal is to evaluate whether a linear combination of regression
coefficients aT βg is equal to zero. We assume that a priori each gene has probability
p to be non-differential (H0 : aT βg = 0) and probability 1 − p to be differential (H1 :
aT βg ̸= 0). When a gene is differential, assume aT β̂g/
√︂
var(aT β̂g) ∼ N(0, 1 + τ 2).
We use an Expectation-Maximization algorithm to estimate p and τ 2. The posterior
probability for H1 is used to detect and rank DE genes. Treating the posterior
probability of H0 as a local false discovery rate, a global FDR can also be calculated
as in [102] to compare with other methods.
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Note that besides the single-cell methods discussed before (Seurat, MAST, scDD,
t test), another existing approach to run DE analysis is to pool cells in each cell
subpopulation and then analyze cells’ average expression as bulk samples using existing
bulk DE methods such as limma, DESeq2, and edgeR. This approach ignores the
cell-level variability, which is similar to removing the ˜︁e component from the LMM.
When the cell-level variability is comparable to the sample-level variability, ignoring
cell-level variability will substantially underestimate the uncertainty of βg estimates,
which can lead to incorrect error rate estimates and reduced statistical power. Note
also that variance shrinkage has been used in the past in linear model (LM) settings
(e.g., limma, DESeq2 and edgeR). However, the LM only requires one level of variance
modeling, whereas the LMM requires multi-level variance modeling. Imposing prior
distributions on both the sample-level and cell-level variances makes the model fitting
complicated. It is difficult to directly apply algorithms in limma, DESeq2 and edgeR.
One solution to fitting the model is to use the fully Bayesian approach and run Markov
Chain Monte Carlo. However, this approach is slow and not scalable to large datasets.
In order to make the model fitting scalable, we developed a computationally efficient
multi-step fitting algorithm that sequentially estimates ˜︁Ωg, ˜︁Σg, β, p, τ 2, and the
posterior probability of DE.
The regression framework adopted by RAISIN is flexible. Besides comparing
two groups of samples, it can also be used to analyze the association between gene
expression and any other categorical or continuous variables. One can also add
covariates to the model to adjust for potential confounding. For instance, one can
formulate a model to identify DE associated with age after accounting for experimental
batches:
˜︁ygs = βg0 + βg1 × ages + βg2 × batchs + ugs + ˜︁egs (4.13)
Here, the design matrix ˜︂X will contain 1 (for intercept), age and batch. The DE will
be detected by evaluating βg1.
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RAISIN can be further generalized to allow L groups of arbitrary random factors:







var([ug1,ug2, ...,ugL]) = diag(σ2g1, ..., σ2g1, σ2g2, ..., σ2g2, ..., σ2gL, ..., σ2gL)
This formulation allows more flexible types of differential analysis. Below gives an
example of identifying differential genes between two cell subpopulations k1 and k2.
Let ygsc,k denote gene expression for gene g, sample s, and cell c in cell subpopulation
k. Let ˜︁ygs,k be gene g’s average expression in sample s across cells in cell subpopulation
k. For instance, suppose there are four samples and no other covariates to adjust for,
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var(˜︁eg) = ˜︁Ωg = diag {︃ω2g1,k1n1,k1 , . . .
}︃
.
Methods to estimate ω2gs,k and σ2gi can be found below. When there are covariates,
they can be added to the design matrix ˜︂X.
4.2.4 Estimating θs,ϕs and ω2gs
Denote vgs as the sample variance across all cells for sample s and gene g.
















where B(., .) denotes beta distribution.
Thus, θs
ϕs
vgs ∼ F (ds, 2θs) and 12 log(
θs
ϕs
vgs) ∼ z(ds, 2θs)
where z(., .) denotes Fisher’s z-distribution.
E[log(vgs)] = log(2ϕs/ds) + ψ(ds/2) − ψ(θs)
var[log(vgs)] = ψ′(ds/2) + ψ′(θs)
where ψ(.) and ψ′(.) are the digamma and trigamma functions respectively.
If var[log(vgs)] − ψ′(ds/2) > 0
θs = ψ′−1(var[log(vgs)] − ψ′(ds/2))
ϕs = exp(E[log(vgs)] − ψ(ds/2) + ψ(θs)) ∗ ds/2
Since ω2gs|vgs ∼ IG(θs + ds/2, dsvgs/2 + ϕs)









If θ + d/2 > 1, E[ω2gs|vgs] =
dsvgs/2+ϕs
θs+ds/2−1 . Otherwise E[ω
2
gs|vgs] is derived using
Gauss–Laguerre quadrature.
If var[log(vgs)] − ψ′(ds/2) ≤ 0
E[ω2gs|vgs] = exp(ē), where e = log(vgs)
E[ω2gs|vgs] serves as the estimate of ω2gs.
For situations where ns = 1, E[ω2gs|vgs] = E[ω2gs′|vgs′ ] s.t. s′ = argminj:nj>1(∥βs − βj∥2)
4.2.5 Estimating αl,γl and σ2gl
Suppose there are L groups of random effects.
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αl, γl, σ2gl are estimated iteratively for each group l in the order of ol ( i.e. group l
with smallest ol is estimated first and group l with largest ol is estimated last). Here
ol =
∑︁
i,j I(Zl[i, j] > 0).
To perform the estimation for group l, suppose groups in set Al are already
estimated, and groups in set Bl are not estimated yet (l ̸∈ Bl).
Let Cl = {c|∃ i ∈ {l,Bl} s.t. Zi[c, .] ̸= 0}
Let ˜︂Xl = ˜︂X[Cl, .]
Let ˜︁Zi,l = ˜︂Zi[Cl, .] for i = 1, 2, ..., L
Let ˜︁Σgl = ˜︁Σg[Cl,Cl]
Let ˜︁Ωgl = ˜︁Ωg[Cl,Cl]
Let ˜︁ygl = ˜︁yg[Cl]
Let ˜︁egl = ˜︁eg[Cl]
Find Kl such that Kl˜︂Xl = 0, Kl ˜︁Zi,l = 0 for i ∈ Bl, and KlKTl = I.
Kl˜︁ygl = Kl˜︂Xlβg+∑︁i∈{Al,Bl,l} Kl ˜︁Zi,l˜︁ugi+Kl˜︁egl = ∑︁i∈Al Kl ˜︁Zi,l˜︁ugi+Kl ˜︁Zl,l˜︁ugl+Kl˜︁egl
Kl˜︁ygl| ˜︁Σgl, ˜︁Ωgl ∼ N(0, σ2glKl ˜︁Zl,l(Kl ˜︁Zl,l)T +∑︁i∈Al σ2giKl ˜︁Zi,l(Kl ˜︁Zi,l)T + Kl ˜︁ΩglKTl )
Note that here σ2gi are already estimated for i ∈ Al
Let pigl be the ith element of the vector Kl˜︁ygl
Let qil be the ith diagonal element of the matrix Kl ˜︁Zl,l(Kl ˜︁Zl,l)T




giKl ˜︁Zi,l(Kl ˜︁Zi,l)T +
Kl ˜︁ΩglKTl )
pigl|σ2gl ∼ N(0, σ2glqil + rigl)
Let E[σ2gl] = Ml, E[(σ2gl)2] = Vl
E[p2igl] = E[E[p2igl|σ2gl]] = E[σ2gl]qil + rigl = Mlqil + rigl








E[p4igl] = E[E[p4igl|σ2gl]] = E[3(σ2glqil + rigl)2] = 3E[(σ2glqil)2 + 2(σ2glqil)rigl + r2igl] =
3Vlq2il + 6Mlqilril + 3r2il










αl = M2l /(Vl −M2l )
γl = Ml/(Vl −M2l )
Using Gauss-Laguerre quadrature to calculate the following two integrals:
P (Kl˜︁ygl) = ∫︁R P (Kl˜︁ygl|σ2gl)P (σ2gl) dσ2gl
Eσ2
gl
|Kl˜︁ygl [σ2gl] = ∫︁R σ2glP (Kl˜︁ygl, σ2gl)/P (Kl˜︁ygl) dσ2gl
Eσ2
gl
|Kl˜︁ygl [σ2gl] serves as an estimate of σ2gl.
4.2.6 Hypothesis testing
To test whether a certain contrast aT βg is zero:
H0 : aT βg = 0
H1 : aT βg ̸= 0
βĝ = (XT X)−1XT ỹg
Let k = aT (XT X)−1XT
The test statistics: tg = aT β̂g/
√︂
var(aT β̂g) = k˜︁yg/√︂k˜︁ZΣg ˜︁ZT kT + k ˜︁ΩgkT
Under H0:
tg asymptotically follows N(0, 1) with large sample size.
Under H1:
tg asymptotically follows N(0, 1 + τ 2) with large sample size.
Denote zg = 0 when gene g is non-differential (H0), zg = 1 when gene g is
differential (H1).
P (zg = 1) = p
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Use E-M algorithm to estimate p and τ 2.
E-step:
L = ∏︁g[N(tg, 0, 1 + τ 2)p]I(zg=1)[N(tg, 0, 1)(1 − p)]I(zg=0)
log(L) = l = ∑︁g I(zg = 1)log[N(tg, 0, 1 + τ 2)p] + I(zg = 0)log[N(tg, 0, 1)(1 − p)] =∑︁
g[I(zg = 1)[−log(2π)/2 − log(1 + τ 2)/2 −
t2g
2(1+τ2) + log(p)] + I(zg = 0)[−log(2π)/2 −
t2g
2 + log(1 − p)]]
Let Mg = Ezg |tg ,(τ2)(t),p(t) [I(zg = 1)]
= P [zg = 1|tg, (τ 2)(t), p(t)] = P [tg|zg = 1, (τ 2)(t), p(t)]P [zg = 1|(τ 2)(t), p(t)]/P [tg|(τ 2)(t), p(t)]
= N(tg, 0, 1 + (τ 2)(t))p(t)/[N(tg, 0, 1 + (τ 2)(t))p(t) +N(tg, 0, 1)(1 − p(t))]



















If τ 2 < 0, τ 2 is set to be 0.
When E-M converges, Mg is treated as posterior probability for differential.
4.2.7 Benchmark data collection and processing
The bone marrow scRNA-seq data from the Human Cell Atlas (HCA) were downloaded
from [103] and aligned to human hg19 genome using Cell Ranger [24] version 2.1.1. The
data are analyzed using the default RAISIN pipeline. For this analysis, bulk RNA-seq
data (count matrix) of FACS-sorted hematopoietic cell types were downloaded from
the Gene Expression Omnibus (GEO accession number: GSE74246). The counts were
converted to TPM and log2 transformed after adding a pseudocount of 1. DESeq2
was used to call DE genes in bulk RNA-seq (FDR cutoff=0.05).
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4.2.8 Analysis of HCA bone marrow data
For this dataset, differential expression are detected by RAISIN with FDR < 0.05. To
benchmark the performance, we annotated the cell type of each cell subpopulation
using cell-type specific marker genes which were derived from bulk RNA-seq data from
13 FACS-sorted hematopoietic cell types. In bulk RNA-seq, gene expression profiles of
replicate samples were averaged for each cell type. For each pair of cell types k1 and
k2, genes were ranked based on differences in gene expression between the two cell
types, and the top 100 genes upregulated in each cell type were obtained as a marker
gene set.
We first assigned an initial cell type label for each individual cell. For each marker
gene set, genes’ average expression was calculated for each bulk RNA-seq sample.
These data were arranged as a matrix B, where each row represents a marker gene
set and each column represents a bulk RNA-seq sample. Similarly, the averaged
expression of each marker gene set was also calculated for each cell in the scRNA-seq
data. Denote the resulting matrix as C, where each row represents a marker gene set
and each column represents a cell. For both matrices, each row was standardized across
samples or cells to have zero mean and unit variance. For each cell i, the Spearman
correlation between the i-th column of C and each column of B was calculated. If the
maximum correlation was above 0.6, we assigned the cell type corresponding to the
maximum correlation to cell i. Otherwise, the cell was not assigned any cell type.
We then assigned cell type for each cell cluster. For each cluster, the proportion of
cells from each cell type was computed. The cell type with the largest proportion was
identified. If this largest proportion was larger than 0.7, then this cell type was used
to annotate the cell cluster. Otherwise, the cell cluster was annotated as unknown cell
type. After cell type annotation, the performance of differential analysis of scRNA-seq
in each cell cluster was evaluated.
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4.2.9 Simulation study
We generated simulation data based on the HCA bone marrow scRNA-seq dataset.
Eight simulated samples were created using randomly sampled cells from the eight
bone marrow samples. For each bone marrow sample, cells were drawn from four
cell types including common lymphoid progenitor (CLP), monocyte, erythroid and
hematopoietic stem cell (HSC) to create a simulated sample consisting of four cell
types.
Baseline simulation. The eight simulated samples were partitioned into two
groups, denoted as S1 and S2. Each group contained four samples. Differences in
cell proportion between the two sample groups were introduced for monocyte and
HSC, but not for CLP and erythroid. To implement this, each simulated sample s
was created by randomly drawing as CLP cells, bs erythroid cells, cs HSC cells and
ds monocyte cells from the corresponding HCA bone marrow sample. Here as was a
random integer uniformly drawn from the interval [5, 10]. The ass for 8 samples were
independently generated. Similarly, bs was a random integer uniformly distributed
in interval [40, 50]. cs was also an random integer, but its distribution was different
for the two sample groups. For samples in S1, cs was uniformly drawn from [5, 10].
For samples in S2, cs was uniformly drawn from [40, 50]. Similarly, ds was a random
integer with different distributions for the two sample groups. For samples in S1, ds
was uniformly drawn from [40, 50]. For samples in S2, cs was uniformly drawn from
[5, 10]. After sampling cells, the expression profiles (including raw read counts, scran
normalized values, and SAVER imputed values) of the sampled cells were carried over
to the simulated sample. RAISIN cell clustering was then performed using the SAVER
imputed gene expression to group all cells into four clusters. This baseline simulation
procedure generated two groups of simulated samples with differential cell proportion
for HSC and monocyte and non-differential cell proportion for CLP and erythroid. In
this baseline simulation, the gene expression profile of each cell type was not expected
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to be differential between the two sample groups because S1 and S2 were obtained by
partitioning samples of the same type (i.e., they were all bone marrow samples).
Simulation 1. In order to benchmark detection of DE between two groups of
samples, we further introduced differentially expressed genes on top of the samples
generated by the baseline simulation. We simulated a total of 48 datasets through
combinations of 3 different DE gene proportions, 4 cell types, and 4 different magnitude
of differential signals. Let G denote the total gene number, and p be the proportion
of genes that are differential. In each simulation dataset, one cell type was chosen
to introduce DE, and the other three cell types remained the same and thus did not
contain DE. For the chosen cell type, DE was introduced to p ∗G randomly chosen
genes so that p2 ∗G genes were upregulated in sample group S1 and the other
p
2 ∗G
genes were upregulated in S2. The DE signal for the p2 ∗G genes upregulated in S1 was
introduced as follows. For the cell type in question, let C1 denote the set of all cells in
sample group S1, and let Y1 denote the expression matrix of the p2 ∗G selected genes
in cells in C1. We first randomly sampled the same number of cells with the same cell
type from the bone marrow scRNA-seq data and denote this new set of cells as C2.
In C2, we removed genes with zero expression across all cells. The remaining genes
were stratified into four equal-sized groups based on each gene’s average expression
across cells in C2. The four strata corresponded to genes with expression from high
to low. We then picked up a stratum and randomly sampled p2 ∗ G genes from the
stratum. Let Y2 denote the expression matrix of these p2 ∗ G genes in cells in C2.
Note that the matrix dimension of Y2 was the same as the dimension of Y1. We
added Y2 to Y1 and used their sum to replace Y1 in the original data matrix. In
this way, upregulation was introduced to p2 ∗G genes in sample group S1. Depending
on which of the four gene strata was chosen from C2 to generate Y2, four different
magnitudes of differential expression can be introduced. Using a similar procedure,
the DE signal for the p2 ∗G genes upregulated in S2 was introduced. This creates one
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simulation dataset. By selecting different cell types to simulate DE (there were 4 cell
types in total), setting DE gene proportion to 3 different values (p = 0.02, 0.1, 0.2)
and introducing 4 different magnitudes of DE signals, a total of 48 simulation datasets
were created. Different DE analysis methods were then run on each dataset to detect
DE between the two sample groups S1 and S2.
Simulation 2. In order to benchmark detection of DE between two cell types, we
introduced DE genes on top of the samples generated by the baseline simulation as
follows. Given a cell type pair, in order to create a clean non-differential background,
we first randomly sampled 10% of all genes as the evaluation gene set T . For each gene
in T , we then randomly permuted cells’ expression values across the two cell types
within each sample. After this step, all genes in T should be non-differential between
the two cell types. We then added DE to p ∗ T genes in gene set T using the same
approach as in simulation 1, but only in T . Our performance evaluation was based on
genes in T only because the true differential status of the remaining 90% genes not
included in T was unknown. The reason we only chose 10% of genes as the evaluation
gene set is that if we chose too many genes and made them non-differential using
permutation, the two cell types would become the same and could not be separated
into two cell populations by cell clustering. The procedure above creates one simulation
dataset. By selecting different cell type pairs to simulate DE (there were 6 cell type
pairs in total), setting DE gene proportion to 3 different values (p = 0.02, 0.1, 0.2) and
introducing 4 different magnitudes of DE signals, a total of 72 simulation datasets
were created. Different DE analysis methods were then run on each dataset to detect
DE between two cell types.
4.2.10 Performance evaluation by AUC and FDR difference
To evaluate a method’s overall ability to detect DE genes, the sensitivity (y-axis) was
plotted as a function of FDR (x-axis). The area under the sensitivity-FDR curve
115
Table 4-I. List of differential methods compared.
Method Type Preprocessing Reference
limma Bulk RNA-seq Raw Count, SAVER Imputed [97]
DESeq2 Bulk RNA-seq Raw Count [104]
edgeR Bulk RNA-seq Raw Count [105]
t test scRNA-seq Raw Count, SAVER Imputed [106]
wilcoxon test (Seurat) scRNA-seq Raw Count, SAVER Imputed [42]
MAST scRNA-seq Raw Count, SAVER Imputed [95]
limma (dupcor) scRNA-seq Raw Count, SAVER Imputed [107]
scDD scRNA-seq Raw Count, SAVER Imputed [94]
DESeq2 scRNA-seq Zinbwave [108]
edgeR scRNA-seq Zinbwave [108]
(AUC) was calculated for each method. The calculation only considers the curve up
to FDR ≤ 0.25 since in practice users usually only care about findings with relatively
small FDR. For simulations, the true DE status of each gene was known. Thus,
sensitivity and FDR were computed using genes’ true DE status.
To evaluate whether a method can accurately estimate FDR, we computed the
difference between the real FDR and reported FDR. For each method, this difference
was plotted as a function of real FDR. We computed the area under the curve up
to real FDR ≤ 0.25 and called this area “FDR difference”. If the FDR difference is
negative, the real FDR overall is smaller than the reported FDR, and the method is
conservative. If the FDR difference is positive, the real FDR overall is larger than the
reported FDR, and the method is too optimistic and reports misleading error rates.
4.3 Results
4.3.1 Simulation study
We compared RAISIN and the most commonly used DE methods in simulations where
in silico differential signals were added to non-differential background constructed
using real scRNA-seq data from biological replicates. Among the compared methods,
Wilcoxon test (used by Seurat [42]), t-test, MAST [95] and scDD [94] ignore sample-
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level variance. They treat cells from biological replicates as if they were from one
sample. They were run using both SCRAN [99] normalized data without imputation
and SAVER [109] imputed data. DESeq2 [104], edgeR [105] and limma [97] are bulk
DE methods. They do not consider cell-level variance. To run them, cells in each
sample and cell cluster were pooled to create a pseudo-bulk sample. Pseudo-bulk
samples were then analyzed as if they were bulk samples. DESeq2 and edgeR are based
on modeling read counts. Thus, they were run using both counts and ZINB-WaVE
[108] corrected data. Limma also provides a LMM (limmacell [rename-limma-LMM])
originally designed for handling random effects of microarray probesets. Since limma
accepts both continuous data and discrete counts, limma and limmaLMM were run
using both read counts (normalized by total library size) and SAVER imputed values.
RAISIN were run in four different modes that either use scran normalized unimputed
data or SAVER imputed data as input, and with or without variance regularization.
RAISIN without variance regularization (RAISIN-LMM) reduces to the classical LMM.
For comparing the same cell cluster between two groups of samples, all methods except
for RAISIN and RAISIN-LMM failed to control false discovery rates (FDR) (Figure 4-
1C). RAISIN with variance regularization substantially outperformed RAISIN-LMM
without variance regularization in terms of the sensitivity-FDR curve characterized by
the area under the curve (AUC) (Figure 4-1C).
4.3.2 HCA bone marrow data
To test RAISIN in real data, we analyzed Human Cell Atlas (HCA) [69] bone marrow
scRNA-seq data from 8 healthy donors. After sample alignment, we identified 44 cell
clusters distributed along three major hematopoietic differentiation lineages consistent
with the known biology (Figure 4-2A). We performed a null DE analysis by randomly
partitioning the samples into two groups. The analysis was run both using all samples
and cells and randomly subsampled samples and cells. There should be no DE genes
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Figure 4-1. A. Schematic of RAISIN algorithm. B. Methods that ignore cell-level
variability (limma) or sample-level variability (Wilcoxon test) yield false positives. C.
AUROC and FDR difference of different methods in a simulation study
between the two sample groups. However, most methods reported over 100 DE genes
at their claimed 5% FDR cutoff in at least one analysis (Figure 4-2C). Here only
RAISIN (SAVER or SCRAN) and RAISIN-LMM (SCRAN) reported fewer than 100
DE genes. Figure 4-1B left panel shows an example to illustrate why methods that
ignore cell-level variability (e.g., limma) failed. This gene is non-differential since the
cell-level variability is larger than the observed difference between groups. However,
when cells from each sample are collapsed into a bulk sample, this variability is not
reflected in the averaged bulk expression which appeared to be differential between the
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two groups. This yields an overly optimistic FDR of 4.35∗10−3 by limma. Figure 4-1B
right panel shows an example to illustrate why methods that ignore sample-level
variability (e.g., Wilcoxon test) failed. This gene is non-differential since the sample-
level variability is larger than the observed difference between groups. However, when
cells from biological replicates are treated as if they were independently drawn from
one sample, the degrees of freedom of the hypothesis test are falsely determined by
the cell number which is large. This yields an overly optimistic FDR of 5.06 ∗ 10−39
by Wilcoxon test. In both cases, RAISIN reported an FDR of 1.
The regression framework adopted by RAISIN is flexible. Besides comparing two
sample groups or two cell types, it can also be used to analyze the association between
gene expression and any other categorical or continuous variables. One can also
add covariates to the model to adjust for potential confounding (Online Methods).
Figure 4-2B compares computation time of different methods for comparing two
sample groups in a single cell cluster. The time increases as a function of cell number.
The LMM used by limma (limmadupcor) and MAST are not scalable to atlas-scale
datasets, and the classical LMM (RAISIN-LMM) is slow. Compared to the classical
LMM, RAISIN is 8 times faster and can handle a two-group comparison of a cell
cluster with 105 cells in 12 minutes. The computational efficiency of RAISIN is in
between Wilcoxon test and bulk DE analysis methods (i.e., limma, DESeq2, edgeR).
Thus, RAISIN not only improves statistical power and false discovery rate estimation
of the DE analysis, but is also scalable to atlas-level analyses.
4.4 Discussion
With the reduced cost of single-cell sequencing technologies, single-cell RNA-seq data
with multiple samples start to emerge in recent years. Most existing methods to
identify differential genes consider only sample-level variability or cell-level variability.















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4-2. A. UMAP of the HCA dataset B. Computational time (y-axis) with different
number of cells in the dataset (x-axis). C. Number of false positives with different number
of cells and different number of samples.
power. The classical linear mixed model is able to consider both sample-level and cell-
level variability, but it scales poorly and has an unstable variance estimate with a small
number of cells or samples. To address these issues, we developed a novel statistical
model, RAISIN, that performs differential analysis for single-cell gene expression data
with multiple samples. RAISIN models both sample-level and cell-level variability, and
combines Bayesian shrinkage estimators to stabilize variance estimate with a small
number of cells and samples. RAISIN also improves the scalability of the classical
linear mixed model by reducing the dimensionality of the data. RAISIN has the best
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statistical power while controls the false positive rate among all existing methods. The
differential genes identified by RAISIN can be used to study the molecular mechanism
that differentiates different groups of samples for each cell type.
In the future, RAISIN can be further extended to study the differential activities
of other types of genomic information. For example, combined with the predicted
chromatin accessibility using gene expression [89], RAISIN is able to identify cis-
regulatory elements that have differential activities across groups of samples. A
differential cis-regulatory element in the promoter region of a differential gene may
help explain the mechanism of the gene’s differential expression. Similar analyses can
also be done for DNA methylation, histone modification and other types of epigenomic
signals.
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Conclusions and general discussion
Single-cell sequencing has become a powerful tool in biomedical research. It grants
researchers unprecedented resolution in studying cell diversity, cell differentiation,
and many other biological processes. Analyzing data from single-cell sequencing is
challenging, and new statistical and machine learning methods are needed. In this
thesis work, we developed statistical methods that computationally order cells to
infer the underlying biological process, enhance the highly sparse single-cell ATAC-seq
data to better infer the gene regulatory programs, and perform differential analysis
to identify molecular signatures that differentiate different groups of samples. These
methods can extract useful information from the highly sparse, noisy and complex
data from single-cell sequencing. Such information may provide crucial insights into
the biological process.
Single-cell sequencing technologies are evolving rapidly. New types of technologies
keep emerging, which continuously brings new challenges in analyzing the data. Novel
statistical and computational methods also provide new approaches to extracting
useful biological and clinical information from the data. Thus, the development of
new statistical approaches is equally important as the development of new single-cell
sequencing technology. In the near future, it will be especially important to develop
new methods in three directions.
First, highly scalable methods need to be developed to efficiently integrate and
analyze single-cell data from multiple samples. Thanks to the advancement of single-
cell sequencing technology, the cost of single-cell experiments continue to decrease.
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In recent years, large-scale datasets from single-cell RNA-seq with many samples or
patients start to emerge [28, 96]. Analytical methods have been developed to address
certain issues for such datasets, such as methods to integrate data across individuals [41,
42] and method developed in this thesis to identify genes with differential expression.
However, there are still many issues that remain to be solved. For example, many
current methods are only tested and applied for datasets with thousands to millions of
cells. Their scalability may not be able to handle datasets with billions or even larger
amounts of cells, which may appear in the near future with the next generation of
single-cell sequencing technology (e.g. celsee). While the integration of gene expression
profile across multiple samples has been relatively well studied, how to integrate other
types of genomic information such as T cell receptor sequence from multiple individuals
remains an open question. While the current methodology development has been
focused on comparing the average expression between groups of samples, the method
to identify genes or molecular signatures with differential variation or differential
pattern along pseudotime across groups of samples is still lacking.
Second, methods that can integrate single-cell data from multiple modalities need
to be developed. While single-cell gene expression profiling is relatively mature
and has been widely used, other types of single-cell technologies such as single-cell
ATAC-seq and single-cell DNA methylation are still immature and less prevalent.
Thus, computationally predicting one type of genomic information using the other
is a useful complement to the experimental approach. For example, we have already
demonstrated that it is possible to predict chromatin accessibility using gene expression
information for single cells with reasonable accuracy [110]. A similar idea can be
used to predict other types of epigenetic signals such as histone modification, DNA
methylation, and DNA 3D structure. Since currently technology still cannot reliably
measure multiple data modalities in one single cell, the prediction methods can also
serve as an important bridge between different modalities from experimental data.
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For example, to align data from single-cell RNA-seq and single-cell ATAC-seq, we
can predict the chromatin accessibility for single-cell RNA-seq data and align it with
the experimental chromatin accessibility from single-cell ATAC-seq. Other potential
directions include to combine CRISPR-based perturbations with single-cell RNA-seq
[111] and single-cell ATAC-seq [112] to better study gene regulatory network, as
well as combine spatial information with single-cell sequencing data to study spatial
transcriptomics and spatial epigenomics.
Third, methods need to be developed to translate the information from single-cell
data to discoveries in biology and improvement in clinical practice. For example,
highly scalable machine learning methods such as deep neural network can be used to
link patients’ response to certain therapy with single-cell data, and to elucidate the
molecular mechanism explaining different treatment outcomes. This information can
be used to find new biomarkers to predict patients’ early outcomes or to improve the
therapy to benefit more patients. Single-cell data can also be used to deconvolve bulk
sequencing data collected from a large population cohort. This information can be
further used to adjust for confounding effects of different cell type compositions in
association studies such as epigenome-wide association studies, which leads to more
accurate identification of epigenetic marks associated with certain traits.
In summary, new statistical and computational methods to extract useful infor-
mation from the single-cell sequencing data are still much needed. Combined with
new single-cell sequencing technologies, these methods will ultimately lead to a deeper
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Software
Methods for analyzing single-cell genomic data
• SCATE: Single-cell ATAC-seq signal extraction and enhancement [Github]
• TSCAN: Pseudo-time reconstruction in single-cell RNA-seq analysis [Bioconduc-
tor] [Github] [GUI]
• BIRD: Big data regression for predicting DNase I hypersensitivity [Github]
• SCRAT: Single-cell regulome analysis tool [Github] [GUI]
• STIP: State transition inference prediction [Github]
• iXplore: Reproducible interactive data exploration tool [GUI]
• SEPA: Single-cell gene expression pattern analysis [Bioconductor] [Github] [GUI]
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• SIMEX: Single-cell immune profiling and gene expression [GUI]
Methods for analyzing large-scale multi-modal genomic data
• GSCA: Gene set context analysis [Bioconductor] [Github] [GUI]
• BIRD: Big data regression for predicting DNase I hypersensitivity [Github]
• DynaMO: Dynamic motif occupancy analysis [Github]
• GEOsearch: Extendable search engine for gene expression omnibus [Bioconduc-
tor] [Github] [GUI]
Methods for high-dimensional statistics
• RMRCE: Regularized maximum rank correlation estimator [Github]
Software designed for teaching
• Statistics toolbox [Apple App Store]
• Graderanalytics [GUI]
Teaching
• Guest lecturer, Statistics in Genomics. 2018, 2019, 2020
• Lead teaching assistant and lab instructor, Statistical Methods in Public Health.
2016-2019





• Statistics in Biosciences
Presentations
Contributed Talks
• Single-cell ATAC-seq signal extraction and enhancement with SCATE. ENAR,
March, 2020
• Reproducible interactive data visualization and exploration with iXplore. ENAR,
March, 2017
• Reproducible interactive data visualization and exploration with iXplore. The
10th International Chinese Statistical Association International Conference,
December, 2016
• TSCAN: Pseudo-time reconstruction and evaluation in single-cell RNA-seq
analysis. Joint Statistical Meeting, August, 2016
Posters
• Single-cell ATAC-seq signal extraction and enhancement with SCATE. RECOM-
B/ISCB Conference on Regulatory & Systems Genomics, December, 2018
• Turning publicly available gene expression data into discoveries using gene set
context analysis. The American Society of Human Genetics Annual Meeting,
October, 2015
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• Turning publicly available gene expression data into discoveries using gene set
context analysis. International Genetic Epidemiology Society Annual Meeting,
October, 2015
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